{
    "paper_id": "0b99f04241566a49e266f6b6848f7714b7aaad05",
    "metadata": {
        "title": "Interferons and Their Use in Persistent Viral Infections",
        "authors": [
            {
                "first": "St\u00e9phane",
                "middle": [],
                "last": "Chevaliez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jean-Michel",
                "middle": [],
                "last": "Pawlotsky",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Abstract In 2007, the world celebrated the 50th anniversary of the discovery of interferon (IFN) by Isaacs and Lindenmann. Subsequently, the IFN-\u03b1 gene was cloned, fully sequenced and IFN-\u03b1 was produced in recombinant form. Recombinant IFN-\u03b1 is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections. IFNs have also been used in other viral infections, although with less success. The antiviral mechanisms of IFNs are reviewed in this chapter as well as the utility of IFNs in the treatment of persistent viral infections.",
            "cite_spans": [
                {
                    "start": 100,
                    "end": 110,
                    "text": "Isaacs and",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Caspase recruitment domains ds Double-stranded ERK 1/2 Extracellular signal-regulated kinase 1/2 GAF \u03b3-IFN activation factor GAS \u03b3-IFN activation site In 2007, the world celebrated the 50th anniversary of the discovery of interferon (IFN) by Isaacs and Lindenmann (Isaacs and Lindenmann 1957) . Human IFN-\u03b1 was the first cytokine to be purified to homogeneity. Subsequently, the IFN-\u03b1 gene was cloned, fully sequenced and IFN-\u03b1 was produced in recombinant form in E. coli (Nagata et al. 1980) . Recombinant IFN-\u03b1 is now used as the basis for treatment of chronic hepatitis C virus (HCV) infection and can also be used to treat certain forms of chronic hepatitis B virus (HBV) infections. IFNs have also been used in other viral infections, although with less success.",
            "cite_spans": [
                {
                    "start": 242,
                    "end": 292,
                    "text": "Isaacs and Lindenmann (Isaacs and Lindenmann 1957)",
                    "ref_id": "BIBREF83"
                },
                {
                    "start": 472,
                    "end": 492,
                    "text": "(Nagata et al. 1980)",
                    "ref_id": "BIBREF135"
                }
            ],
            "ref_spans": [],
            "section": "CARD"
        },
        {
            "text": "IFNs are natural glycoproteins produced by the cells of most vertebrates in response to the challenge by foreign agents, such as infectious organisms (viruses, bacteria, fungi, and parasites), and by tumor cells. IFNs can be produced by cells of the innate and adaptive immune systems and by non-immune cells such as fibroblasts and epithelial cells.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Interferons"
        },
        {
            "text": "Type I IFNs form a superfamily of innate cytokines that comprise IFN-\u03b1 (alpha), with 13 human subtypes, IFN-\u03b2 (beta), IFN-\u03c9 (omega), IFN-\u03c4 (tau), IFN-\u03ba (kappa), IFN-\u03b5 (epsilon) , IFN-\u03bb (lambda) , and IFN-\u03b6 (zeta) (Pestka et al. 2004) . Only IFN\u03b1, IFN-\u03b2, IFN-\u03c9, IFN-\u03ba, and IFN-\u03b5 are expressed in humans. All IFN-\u03b1 subtypes are secreted by leukocytes, whereas IFN-\u03b2 is also produced by fibroblasts. IFN-\u03c4 is exclusively expressed in ruminants at a specific stage of pregnancy (Martal et al. 1998) , whereas IFN-\u03ba is expressed by human keratinocytes (LaFleur et al. 2001) .",
            "cite_spans": [
                {
                    "start": 161,
                    "end": 176,
                    "text": "IFN-\u03b5 (epsilon)",
                    "ref_id": null
                },
                {
                    "start": 179,
                    "end": 193,
                    "text": "IFN-\u03bb (lambda)",
                    "ref_id": null
                },
                {
                    "start": 213,
                    "end": 233,
                    "text": "(Pestka et al. 2004)",
                    "ref_id": "BIBREF154"
                },
                {
                    "start": 474,
                    "end": 494,
                    "text": "(Martal et al. 1998)",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 547,
                    "end": 568,
                    "text": "(LaFleur et al. 2001)",
                    "ref_id": "BIBREF103"
                }
            ],
            "ref_spans": [],
            "section": "Type I IFNs"
        },
        {
            "text": "There are 17 human type I IFN genes, all clustering on chromosome 9. They are intronless and encode secretory signal peptide sequences that are proteolytically cleaved prior to secretion from the cell. Type I IFNs are genetically and structurally closely related. They range in length from 161 to 208 amino acids and have apparent molecular weights of 15-24 kDa (Table 1) (Chen et al. 2004) . The different subtypes of human IFN-\u03b1 have approximately 50% amino acid sequence identity, whereas IFN-\u03b1 shares approximately 22% amino acid identity with human IFN-\u03b2 and 37% with human IFN-\u03c9 (Chen et al. 2004 ).",
            "cite_spans": [
                {
                    "start": 372,
                    "end": 390,
                    "text": "(Chen et al. 2004)",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 585,
                    "end": 602,
                    "text": "(Chen et al. 2004",
                    "ref_id": "BIBREF28"
                }
            ],
            "ref_spans": [
                {
                    "start": 362,
                    "end": 371,
                    "text": "(Table 1)",
                    "ref_id": "TABREF2"
                }
            ],
            "section": "Type I IFNs"
        },
        {
            "text": "There is only one known type II IFN, IFN-\u03b3, discovered in 1965 (Wheelock and Sibley 1965) . IFN-\u03b3 is exclusively produced by immune cells, such as activated thymus-derived T cells and natural killer (NK) cells, after stimulation by foreign antigens or mitogens in the early stages of the innate immune response (Boehm et al. 1997) . The human IFN-\u03b3 gene maps to chromosome 12. IFN-\u03b3 is a noncovalent (Ealick et al. 1991) . The 23-residue hydrophobic signal sequence is removed by proteolytic cleavage prior to secretion from the cell (Table 1) (Boehm et al. 1997 ).",
            "cite_spans": [
                {
                    "start": 37,
                    "end": 76,
                    "text": "IFN-\u03b3, discovered in 1965 (Wheelock and",
                    "ref_id": null
                },
                {
                    "start": 77,
                    "end": 89,
                    "text": "Sibley 1965)",
                    "ref_id": "BIBREF193"
                },
                {
                    "start": 311,
                    "end": 330,
                    "text": "(Boehm et al. 1997)",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 400,
                    "end": 420,
                    "text": "(Ealick et al. 1991)",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 544,
                    "end": 562,
                    "text": "(Boehm et al. 1997",
                    "ref_id": "BIBREF13"
                }
            ],
            "ref_spans": [
                {
                    "start": 534,
                    "end": 543,
                    "text": "(Table 1)",
                    "ref_id": "TABREF2"
                }
            ],
            "section": "Type II IFNs"
        },
        {
            "text": "Recently, a novel class of type I-like human IFNs, named IFN-\u03bb1 or IL-29, IFN-\u03bb2 (IL-28A) and IFN-\u03bb3 (IL-28B), was identified (Dumoutier et al. 2003; Sheppard et al. 2003) . The three IFN-\u03bb genes cluster on human chromosome 19 and comprise 5 exons for IFN-\u03bb1 and 6 for IFN-\u03bb2 and IFN-\u03bb3, and several introns (Table 1) . They encode 20-to 22-kDa secreted monomeric proteins of 196 to 200 amino acids. Type III IFNs have also been identified in other species such as mice, birds, and fish.",
            "cite_spans": [
                {
                    "start": 126,
                    "end": 149,
                    "text": "(Dumoutier et al. 2003;",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 150,
                    "end": 171,
                    "text": "Sheppard et al. 2003)",
                    "ref_id": "BIBREF172"
                }
            ],
            "ref_spans": [
                {
                    "start": 308,
                    "end": 317,
                    "text": "(Table 1)",
                    "ref_id": "TABREF2"
                }
            ],
            "section": "Type III IFNs"
        },
        {
            "text": "Production of types I and III IFNs is an essential component of the innate immune response, the first line of defense against an invading pathogen (Gale and Foy 2005) . IFNs exert auto-and paracrine actions within a few hours in response to a viral infection. Their protective function is dual: they induce an antiviral cellular state and facilitate the clearance of infected cells by activating apoptosis, in synergy with other proapoptotic agents such as tumor necrosis factor (TNF) family members, depending on the intracellular level of double-stranded (ds) RNAs (Clemens 2003 ).",
            "cite_spans": [
                {
                    "start": 147,
                    "end": 166,
                    "text": "(Gale and Foy 2005)",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 567,
                    "end": 580,
                    "text": "(Clemens 2003",
                    "ref_id": "BIBREF29"
                }
            ],
            "ref_spans": [],
            "section": "IFN Production during Viral Infections"
        },
        {
            "text": "Most cell types recognize incoming RNA or DNA viruses, owing to the presence of intracellular RNAs with a 5 triphosphate end (i.e. lacking a 5 cap structure) or dsRNA structures generated during viral RNA replication. Indeed, dsRNA replication intermediates are essential for the synthesis of new RNA genomes, whereas DNA viruses often have overlapping open reading frames lying in opposite orientations, and these generate mRNA transcripts that can base-pair to form dsRNA stretches. The conserved molecular patterns of dsRNAs are recognized by pattern-recognition receptors (PRR), of which the best known are Toll-like receptors (TLR) and retinoic acid-inducible gene 1 (RIG-1)-like helicase receptors (RLR) (Yoneyama et al. 2004) . TLRs are present at the cell surface and in endosomes and recognize various microbial structures, whereas RLRs are expressed ubiquitously in the cytoplasm and recognize only viral structures. Their activation leads to the production of both type I and III IFNs, and this production appears to be regulated by HCV RNA binding to retinoic acid-inducible gene 1 (RIG-1) or Toll-like receptor 3 (TLR-3) results in the phosphorylation and activation of IRF-3 by the tumor necrosis factor receptor-associated factor-associated nuclear factor \u03baB (NF-\u03baB) activator binding kinase 1 (TBK-1) or inhibitory \u03baB kinase \u03b5 (IKK-\u03b5) protein kinases. The dimer of phosphorylated IRF-3 translocates to the cell nucleus, interacts with its transcription partners, and binds to the cognate-DNA positive regulatory domain (PRD) in the promoter region of IRF-3 target genes, including IFN-\u03b2, resulting in IFN-\u03b2 production and secretion. (b) IRF-7 activation. IRF-7 is a transcription factor and an IFN-stimulated gene (ISG). It is activated after expression by viral components through signaling pathways that overlap with the pathways of IRF-3 activation. IRF-7 phosphorylation, dimerization, and heterodimerization with IRF-3 allow it to bind its cognate virus-responsive element (VRE) in the promoter region of IFN-\u03b1 genes, resulting in the production of various IFN-\u03b1 subtypes that further signal ISG expression. (c) Type I IFN signaling. Type I IFN binding to the receptor signals the activation of the associated Tyk2 and Jak1 protein kinases to direct the phosphorylation and assembly of a Stat1-Stat2 heterodimer and trimeric IFN-stimulated gene factor 3 (ISGF3) complex containing IRF-9. The ISGF3 complex locates to the cell nucleus, where it binds to the IFN-stimulated response element (ISRE) on target genes to direct ISG expression. Adapted from Gale and Foy (Gale and Foy 2005) (Ank et al. 2006; Onoguchi et al. 2007; Uze and Monneron 2007) . Type I IFN production is described in Fig. 1 .",
            "cite_spans": [
                {
                    "start": 710,
                    "end": 732,
                    "text": "(Yoneyama et al. 2004)",
                    "ref_id": "BIBREF198"
                },
                {
                    "start": 2572,
                    "end": 2604,
                    "text": "Gale and Foy (Gale and Foy 2005)",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 2605,
                    "end": 2622,
                    "text": "(Ank et al. 2006;",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 2623,
                    "end": 2644,
                    "text": "Onoguchi et al. 2007;",
                    "ref_id": "BIBREF143"
                },
                {
                    "start": 2645,
                    "end": 2667,
                    "text": "Uze and Monneron 2007)",
                    "ref_id": "BIBREF184"
                }
            ],
            "ref_spans": [
                {
                    "start": 2708,
                    "end": 2714,
                    "text": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ],
            "section": "Viral Triggering of IFN Production"
        },
        {
            "text": "At least 12 different TLRs have so far been identified in mammals (Uematsu and Akria 2007) . TLRs are type I transmembrane PRRs that possess an extracellular domain containing leucine-rich repeats (LRR), a transmembrane domain, and an intracellular signaling domain known as the Toll/IL-1R/resistance (TIR) domain. The difference in the amino acid number and the molecular weight of different TLRs is principally related to differences in the number of LRRs in their extracellular domain, which allow them to recognize different ligands. The TIR domain can interact with various adaptor molecules, such as myeloid differentiation primary response protein 88 (MyD88), TIR domain-containing adaptor inducing IFN-\u03b2 (TRIF), and TRIF-related adaptor molecule (TRAM), thereby activating intracellular signaling pathways.",
            "cite_spans": [
                {
                    "start": 66,
                    "end": 90,
                    "text": "(Uematsu and Akria 2007)",
                    "ref_id": "BIBREF183"
                }
            ],
            "ref_spans": [],
            "section": "TLR Pathways"
        },
        {
            "text": "In cell types other than dendritic cells, RLRs such as RIG-1 and melanoma differentiation-associated gene 5 (MDA-5) appear to play a key role in the response to viral infections (Kato et al. 2005) . RIG-1 contains two tandem caspase recruitment domains (CARD), which are needed to activate NF-\u03baB and IRF-3. Double-stranded RNA binding to the RNA helicase domain of RIG-1 induces a conformational change that exposes the CARD domains to downstream signaling proteins. MDA-5 also contains two CARD domains that can activate the IFN-\u03b2 promoter (Creagh and O'Neill 2006; Seth et al. 2006) . A recent study has shown that the tripartite motif protein 25 (TRIM25), a ubiquitin ligase, catalyzes RIG-1 ubiquitination, a crucial step in the cytosolic pathway by which RIG-1 elicits host antiviral responses (Gack et al. 2007 ).",
            "cite_spans": [
                {
                    "start": 178,
                    "end": 196,
                    "text": "(Kato et al. 2005)",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 541,
                    "end": 566,
                    "text": "(Creagh and O'Neill 2006;",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 567,
                    "end": 584,
                    "text": "Seth et al. 2006)",
                    "ref_id": "BIBREF171"
                },
                {
                    "start": 799,
                    "end": 816,
                    "text": "(Gack et al. 2007",
                    "ref_id": "BIBREF58"
                }
            ],
            "ref_spans": [],
            "section": "RLR Pathways"
        },
        {
            "text": "The induction of type I and III IFN gene transcription is principally controlled by transcription factors NF-\u03baB, IRF-3, and IRF-7 ( Fig. 1 ). In its inactive state, NF-\u03baB is held in the cytosol by members of the inhibitory \u03baB (I\u03baB) family. In the presence of incoming viruses, the I\u03baB kinase (IKK) is activated and phosphorylates I\u03baB, which is subsequently ubiquitinated and degraded by the proteasome. Free NF-\u03baB translocates into the nucleus, where it increases the transcription of target genes. Like NF-\u03baB, the inactive form of IRF-3 is cytosolic. In response to a viral infection, IRF-3 is phosphorylated by two IKK-like kinases: TNF receptor-associated factor (TRAF)-associated NF-\u03baB activator (TANK) binding kinase 1 (TBK-1) and IKK\u03b5. IRF-3 phosphorylation leads to its dimerization and translocation into the nucleus (Hayden et al. 2006; Seth et al. 2006) . IRF-7 is expressed at low levels in most cells. It is also activated through phosphorylation by TBK-1 and IKK\u03b5 (Honda et al. 2005) . NF-\u03baB, IRF-3, IRF-7, and nuclear architecture proteins assemble into a complex in the nucleus that remodels the chromatin in IFN gene promoters, resulting in an increase in transcriptional initiation.",
            "cite_spans": [
                {
                    "start": 825,
                    "end": 845,
                    "text": "(Hayden et al. 2006;",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 846,
                    "end": 863,
                    "text": "Seth et al. 2006)",
                    "ref_id": "BIBREF171"
                },
                {
                    "start": 977,
                    "end": 996,
                    "text": "(Honda et al. 2005)",
                    "ref_id": "BIBREF78"
                }
            ],
            "ref_spans": [
                {
                    "start": 132,
                    "end": 138,
                    "text": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ],
            "section": "IFN Gene Induction"
        },
        {
            "text": "On binding to its receptor, the IFN molecule is sandwiched between the two chains of the receptor, thus forming a ternary complex that activates the canonical Jak/Stat pathway through activation of the transduction elements located in the intracytoplasmic tail of each receptor subunit (Fig. 1) .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 286,
                    "end": 294,
                    "text": "(Fig. 1)",
                    "ref_id": "FIGREF0"
                }
            ],
            "section": "IFN-Induced Signaling Pathways"
        },
        {
            "text": "The similarity of the transcriptional responses induced by type I and type III IFNs has been confirmed by microarray analysis of Jak/Stat pathway gene expression in various cell lines (Doyle et al. 2006; Dumoutier et al. 2004) . Figure 1 shows type I IFN signaling through the Jak-Stat pathway. Type I and III IFN binding to their specific receptor triggers the activation of Jak1 and Tyk2 through tyrosine transphosphorylation. The activated kinases induce the formation of the IFN-stimulated gene factor-3 (ISGF3), itself composed of two elements, ISGF3\u03b1 and ISGF3\u03b3. ISGF3\u03b1 is formed of two cytoplasmic peptides, Stat1 (p91) and Stat2 (p113), which share 42% nucleotide identity. ISFG3\u03b3 is a member of the IRF family, which has been renamed IRF-9. The IRF-9 protein is a single polypeptide with an apparent molecular weight of 48 kDa. It comprises two domains: a conserved amino-terminal DNA-binding domain and a carboxy-terminal Stat-binding domain. IRF-9 is mostly cytoplasmic and inactive in untreated cells. It migrates to the nucleus after IFN treatment. The phosphotyrosyl residues of activated Jak proteins serve as docking sites for Stat1 and Stat2, both of which are phosphorylated on a single tyrosine residue by activated Jak proteins. Stat1 and Stat2 phosphorylation induces their release from the IFNARs and their dimerization through their SH2 domain. Stat1-Stat2 heterodimers then move to the nucleus to form the ISGF3 complex, together with IRF-9 ( Fig. 1 ). ISGF3 then interacts directly with the IFN-stimulated response element (ISRE), a DNA sequence that characterizes ISGs. These may contain one or several ISRE sequences in their promoter sequence. Other Stat proteins have been shown to be activated by type I and III IFNs, but their involvement in IFN responses may be restricted to certain cell types (Takaoka and Yanai 2006) .",
            "cite_spans": [
                {
                    "start": 184,
                    "end": 203,
                    "text": "(Doyle et al. 2006;",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 204,
                    "end": 226,
                    "text": "Dumoutier et al. 2004)",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 1827,
                    "end": 1851,
                    "text": "(Takaoka and Yanai 2006)",
                    "ref_id": "BIBREF182"
                }
            ],
            "ref_spans": [
                {
                    "start": 229,
                    "end": 237,
                    "text": "Figure 1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 1467,
                    "end": 1473,
                    "text": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ],
            "section": "Type I and III IFNs"
        },
        {
            "text": "IFN-\u03b3 receptor subunits IFNGR1 and IFNGR2 trigger the activation of Jak1 and Jak2 through tyrosine phosphorylation. Jak1 and Jak2 activation leads to the formation of a multimeric complex, \u03b3-IFN activation factor (GAF), that transduces the signal to the target DNA sequence in ISGs, known as the \u03b3-IFN activation site (GAS). GAF is a homodimer of tyrosine-phosphorylated Stat1 proteins. GAF exists in latent form in the cell cytoplasm. It can be rapidly activated following IFN-\u03b3 binding to its receptor by phosphorylation at Stat1 tyrosine residue 701. Once activated, GAF translocates into the nucleus and binds GAS sequences to induce ISG transcription. It was recently shown that Stat1-Stat2 heterodimers can also activate GAS elements (Takaoka and Yanai 2006) . In addition, a novel c-Jun-dependent signal transduction pathway induced by type II IFN has been identified. This pathway involves protein kinases other than Jaks, including extracellular signal-regulated kinase 1/2 (ERK1/2) and mitogen-activated/extracellular signal-regulated kinase 1/2 (MEK1/2). This pathway appears to operate in parallel with the canonical Jak/Stat signaling pathway (Gough et al. 2007 ).",
            "cite_spans": [
                {
                    "start": 740,
                    "end": 764,
                    "text": "(Takaoka and Yanai 2006)",
                    "ref_id": "BIBREF182"
                },
                {
                    "start": 1156,
                    "end": 1174,
                    "text": "(Gough et al. 2007",
                    "ref_id": "BIBREF68"
                }
            ],
            "ref_spans": [],
            "section": "Type II IFN"
        },
        {
            "text": "The antiviral state induced by different types of IFNs is mediated by various IFNinduced proteins. The best-known antiviral effectors produced as a result of IFN cascade induction are shown in Table 2 . They include 2 -5 oligoadenylate synthetase (2 -5 OAS), double-stranded RNA activated protein kinase (PKR), and myxovirus (Mx) proteins. Additional effectors include RNA-specific adenosine deaminase 1 (ADAR1), the 20-kDa ISG product (ISG20), ISG54 and ISG56, and IFN-stimulated micro RNAs (Pedersen et al. 2007 ).",
            "cite_spans": [
                {
                    "start": 492,
                    "end": 513,
                    "text": "(Pedersen et al. 2007",
                    "ref_id": "BIBREF152"
                }
            ],
            "ref_spans": [
                {
                    "start": 193,
                    "end": 200,
                    "text": "Table 2",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "IFN Antiviral Effectors"
        },
        {
            "text": "In addition to their direct antiviral properties described earlier, IFNs exhibit potent immunomodulatory properties that contribute to their antiviral effects by activating (Pestka et al. 1987) . IFNs can stimulate the effector function of NK cells, cytotoxic T lymphocytes, and macrophages, upregulate the expression of major histocompatibility complex (MHC) class I and class II molecules, induce immunoglobulin synthesis by B cells, and stimulate the proliferation of memory T cells. This offers various modes to control viral replication, by modulating the innate and adaptive immune responses (Guidotti and Chisari 2001) . Type I IFNs act through activation and maturation of dendritic cells, leading to MHC upregulation. They can also upregulate various chemokines, chemokine receptors, and costimulatory molecules, which, in turn, stimulate CD4-positive and CD8-positive T cell responses and modulate T lymphocyte responses through the promotion of Th1 differentiation (Solis et al. 2006) . IFN-\u03b3 is a major immunoregulatory cytokine involved in the regulation of nearly all phases of immune and inflammatory responses, including activation and differentiation of T cells, B cells, NK cells, and macrophages. The expression of class II MHC molecules on immune cells is principally regulated by IFN-\u03b3, especially on monocytes and macrophages. IFN-\u03b3 also increases the transcription of the \u03b2 2microglobulin light chain of MHC class I molecules. In addition, IFN-\u03b3 regulates T cell functions and modulates neutrophil functions by modulating the surface expression of various molecules, including integrins and chemokine receptors (Gattoni et al. 2006a, b) .",
            "cite_spans": [
                {
                    "start": 173,
                    "end": 193,
                    "text": "(Pestka et al. 1987)",
                    "ref_id": "BIBREF153"
                },
                {
                    "start": 598,
                    "end": 625,
                    "text": "(Guidotti and Chisari 2001)",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 976,
                    "end": 995,
                    "text": "(Solis et al. 2006)",
                    "ref_id": "BIBREF178"
                },
                {
                    "start": 1634,
                    "end": 1659,
                    "text": "(Gattoni et al. 2006a, b)",
                    "ref_id": "BIBREF62"
                }
            ],
            "ref_spans": [],
            "section": "Immunomodulatory Properties of IFNs"
        },
        {
            "text": "Different forms of IFN-\u03b1 have been available for the treatment of chronic hepatitis B and C, including IFN-\u03b12a and IFN-\u03b12b. The administered dose was 3-5 megaunits three times a week subcutaneously.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Standard IFN-\u03b1"
        },
        {
            "text": "Polyethylene glycol (PEG) consists of repeating units of ethylene glycol forming linear or branched polymers with different molecular masses. Pegylation is the process by which PEG chains are covalently attached to IFN molecules. Pegylation confers a number of properties on IFN-\u03b1 molecules, such as sustained blood levels that enhance antiviral effectiveness and reduce adverse reactions, as well as a longer half-life and improved patient compliance (Kozlowski et al. 2001) .",
            "cite_spans": [
                {
                    "start": 452,
                    "end": 475,
                    "text": "(Kozlowski et al. 2001)",
                    "ref_id": "BIBREF101"
                }
            ],
            "ref_spans": [],
            "section": "Pegylated IFN-\u03b1"
        },
        {
            "text": "Two forms of pegylated IFN-\u03b1 have been approved by the Food and Drug Administration (FDA) and by the European Medicines Agency (EMEA) for the ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Pegylated IFN-\u03b1"
        },
        {
            "text": "Other IFNs that can be used in the treatment of viral infections include IFN-\u03b2, IFN-\u03c9, a molecule that is more potent than its nonglycosylated form, which itself has activity comparable to that of IFN-\u03b1 (Buckwold et al. 2007) , and that will be delivered continuously by an implantable device, IFN-\u03b3 and IFN-\u03bb1, a pegylated form of which will soon be available.",
            "cite_spans": [
                {
                    "start": 203,
                    "end": 225,
                    "text": "(Buckwold et al. 2007)",
                    "ref_id": "BIBREF18"
                }
            ],
            "ref_spans": [],
            "section": "Other IFNs"
        },
        {
            "text": "New IFN-\u03b1 molecules are also being developed. They include albumin-IFN-\u03b12b (Alb-IFN-\u03b12b, Human Genome Sciences, Rockville, Maryland, and Novartis, Basel, Switzerland), a novel 87.5-kDa recombinant protein consisting of an IFN-\u03b12b molecule attached to a human albumin moiety. Alb-IFN-\u03b12b has a half-life of up to 159 h, allowing dosing at intervals of 2-4 weeks (Balan et al. 2006) . Pharmacokinetic studies in monkeys showed approximately 140-fold slower clearance and an 18-fold longer half-life than IFN-\u03b1 after a single subcutaneous injection (Osborn et al. 2002) .",
            "cite_spans": [
                {
                    "start": 361,
                    "end": 380,
                    "text": "(Balan et al. 2006)",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 546,
                    "end": 566,
                    "text": "(Osborn et al. 2002)",
                    "ref_id": "BIBREF144"
                }
            ],
            "ref_spans": [],
            "section": "Other IFNs"
        },
        {
            "text": "Novel IFN-\u03b1 variants have been created experimentally by means of DNA shuffling (\"gene-shuffled\" IFN-\u03b1). In this technique, natural IFN-\u03b1 genes are fragmented and then reassembled through recombination, a process that mimics evolution. Gene-shuffled IFN variants may have increased antiviral and antiproliferative activity (Chang et al. 1999) . A library of clones has been generated (Maxygen, Redwood City, California, and Roche) and two clones have been selected for their improved in vitro activity relative to human IFN-\u03b1. One of them has been pegylated but its development has been halted because of strong immune reaction.",
            "cite_spans": [
                {
                    "start": 323,
                    "end": 342,
                    "text": "(Chang et al. 1999)",
                    "ref_id": "BIBREF27"
                }
            ],
            "ref_spans": [],
            "section": "Other IFNs"
        },
        {
            "text": "IFN alphacon-1 (Infergen, Amgen, Thousand Oaks, California) is a synthetic recombinant \"consensus\" IFN-\u03b1 molecule created by scanning the sequences of several natural IFNs and assigning to the recombinant molecule the most frequently observed amino acid at each position (Keeffe and Hollinger 1997) . The intrinsic antiviral activity of this IFN appears to be 10-to 100-fold higher than that of standard IFNs (Blatt et al. 1996; Ozes et al. 1992) . The future of consensus IFN-\u03b1 will depend on the development of a pegylated or otherwise pharmacologically modified form. Multiferon (Viragen, Plantation, Florida) is a highly purified, multi-subtype natural human IFN-\u03b1 derived from human leukocytes. Medusa R (Flamel Technologies, Lyon, France) is a self-assembled poly-aminoacid nanoparticle system that can be used as a protein carrier for novel long-acting native protein drugs. Medusa IFN-\u03b12a and Medusa IFN-\u03b2 are currently in early clinical development. Various types of orally administered IFN-\u03b1 are also being developed.",
            "cite_spans": [
                {
                    "start": 271,
                    "end": 298,
                    "text": "(Keeffe and Hollinger 1997)",
                    "ref_id": "BIBREF98"
                },
                {
                    "start": 409,
                    "end": 428,
                    "text": "(Blatt et al. 1996;",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 429,
                    "end": 446,
                    "text": "Ozes et al. 1992)",
                    "ref_id": "BIBREF145"
                }
            ],
            "ref_spans": [],
            "section": "Other IFNs"
        },
        {
            "text": "Chronic HCV infection is curable, and cure is the goal of antiviral therapy. Successful treatment is characterized by a sustained virological response (SVR), defined by undetectable HCV RNA in a sensitive assay (detection limit \u2264 50 international units (IU)/ml) 6 months after the end of therapy. Recent large-scale follow-up studies have shown no relapse or recurrence after 4-6 years in more than 99% of patients who have an SVR Swain et al. 2007) .",
            "cite_spans": [
                {
                    "start": 431,
                    "end": 449,
                    "text": "Swain et al. 2007)",
                    "ref_id": "BIBREF181"
                }
            ],
            "ref_spans": [],
            "section": "Treatment of Chronic HCV Infection with IFN-\u03b1"
        },
        {
            "text": "The choice of IFN-\u03b1 as a potential treatment for chronic hepatitis C in 1986 was empirical ). At this time, the causative agent of chronic \"non-A, non-B\" hepatitis had not yet been identified, and there was no way of evaluating HCV replication or, thus, the antiviral activity of a drug. In the first cohort of 10 patients with chronic non-A, non-B hepatitis treated with IFN-\u03b1, a significant decline in alanine aminotransferase (ALT) levels was observed in 8 patients, and liver histology had improved at the end of therapy in the three patients who were biopsied ). Ten years later, 5 of the 10 patients were free of infection (Lau et al. 1998 ).",
            "cite_spans": [
                {
                    "start": 629,
                    "end": 645,
                    "text": "(Lau et al. 1998",
                    "ref_id": "BIBREF109"
                }
            ],
            "ref_spans": [],
            "section": "Treatment of Chronic HCV Infection with IFN-\u03b1"
        },
        {
            "text": "The first National Institutes of Health (NIH) Consensus Development Conference on Management of Hepatitis C, held in 1997 (1997) , recommended that standard IFN-\u03b1 be used at the same dose for 48 weeks for the treatment of chronic hepatitis C. However, the SVR rates were still only 12-20% with this treatment schedule (Di Bisceglie and Hoofnagle 2002; Lindsay et al. 2001) . The development of pegylated IFN-\u03b1 was found to ensure sustained drug exposure. Pegylated IFN-\u03b12a is administered at a fixed dose of 180 \u03bcg/week, whereas pegylated IFN-\u03b12b is administered at a weight-adjusted dose of 1.5 \u03bcg/kg/week. Both pegylated IFNs have been reported to yield a twofold higher SVR rate than the corresponding standard IFN-\u03b1 when administered alone for 48 weeks",
            "cite_spans": [
                {
                    "start": 122,
                    "end": 128,
                    "text": "(1997)",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 322,
                    "end": 351,
                    "text": "Bisceglie and Hoofnagle 2002;",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 352,
                    "end": 372,
                    "text": "Lindsay et al. 2001)",
                    "ref_id": "BIBREF118"
                }
            ],
            "ref_spans": [],
            "section": "Standard IFN-\u03b1 and Pegylated IFN-\u03b1 Monotherapy"
        },
        {
            "text": "Ribavirin is a guanosine analogue with a broad spectrum of activity against DNA and RNA viruses (Sidwell et al. 1972) . Ribavirin modestly and transiently inhibits HCV replication in vivo (Pawlotsky et al. 2004 ), but it efficiently prevents relapses during IFN-ribavirin combination therapy (Bronowicki et al. 2006) . The underlying mechanisms are unknown. In the first trial of standard IFN-\u03b1 and ribavirin combination therapy, HCV was eradicated in 40% of patients who received the combination, but in none of those on IFN-\u03b1 monotherapy (Brillanti et al. 1994) . Further randomized controlled trials (McHutchison et al. 1998; Poynard et al. 1998) led to the approval of the standard IFN-\u03b1-ribavirin combination as the standard treatment for chronic hepatitis C, before the development of pegylated IFNs (1999) .",
            "cite_spans": [
                {
                    "start": 96,
                    "end": 117,
                    "text": "(Sidwell et al. 1972)",
                    "ref_id": "BIBREF175"
                },
                {
                    "start": 188,
                    "end": 210,
                    "text": "(Pawlotsky et al. 2004",
                    "ref_id": "BIBREF151"
                },
                {
                    "start": 292,
                    "end": 316,
                    "text": "(Bronowicki et al. 2006)",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 540,
                    "end": 563,
                    "text": "(Brillanti et al. 1994)",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 603,
                    "end": 628,
                    "text": "(McHutchison et al. 1998;",
                    "ref_id": "BIBREF127"
                },
                {
                    "start": 629,
                    "end": 649,
                    "text": "Poynard et al. 1998)",
                    "ref_id": "BIBREF159"
                },
                {
                    "start": 806,
                    "end": 812,
                    "text": "(1999)",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [],
            "section": "IFN-\u03b1-Ribavirin Combination Therapy"
        },
        {
            "text": "Ribavirin is administered at a dose of 0.8-1.2 g/day, depending on body weight and the HCV genotype (2002) . Higher doses may be necessary for heavy patients. The addition of ribavirin increased the SVR rate to 41% and 43%, respectively, compared to 16% and 19% with standard IFN-\u03b12a and IFN-\u03b12b monotherapy (McHutchison et al. 1998; Poynard et al. 1998 ). In the three main registration trials (randomized controlled studies involving patients without cirrhosis), pegylated IFN-\u03b1 plus ribavirin gave global SVR rates of 54-56%, compared to 18-39% with pegylated IFN-\u03b1 monotherapy (Fried et al. 2002; Hadziyannis et al. 2004; Manns et al. 2001 ). The SVR rates ranged from 76% to 84% in patients with HCV genotype 2 or 3 infection and from 42% to 52% in patients with HCV genotype 1 infection. Little information is available on patients with other genotypes, but the SVR rates in patients with HCV genotype 4 infection appear to be close to those in patients with genotype 1 infection. Pretreatment variables that correlated with sustained viral eradication included HCV genotypes 2 and 3, lower baseline viral load, lower body weight, younger age, and milder hepatic fibrosis (Fried et al. 2002; Hadziyannis et al. 2004; Manns et al. 2001) . In pivotal trials approximately 10% of patients discontinued therapy because of adverse events, and dose reductions were required in about 30% of cases (Fried et al. 2002; Hadziyannis et al. 2004; Manns et al. 2001) . Neutropenia and thrombocytopenia were frequently associated with IFN-\u03b1 administration, and hemolytic anemia was the most frequent adverse effect of ribavirin administration (Fried et al. 2002; Hadziyannis et al. 2004; Manns et al. 2001) . Ribavirin-associated anemia can be severe and demand discontinuation or dose reduction.",
            "cite_spans": [
                {
                    "start": 100,
                    "end": 106,
                    "text": "(2002)",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 308,
                    "end": 333,
                    "text": "(McHutchison et al. 1998;",
                    "ref_id": "BIBREF127"
                },
                {
                    "start": 334,
                    "end": 353,
                    "text": "Poynard et al. 1998",
                    "ref_id": "BIBREF159"
                },
                {
                    "start": 581,
                    "end": 600,
                    "text": "(Fried et al. 2002;",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 601,
                    "end": 625,
                    "text": "Hadziyannis et al. 2004;",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 626,
                    "end": 643,
                    "text": "Manns et al. 2001",
                    "ref_id": "BIBREF123"
                },
                {
                    "start": 1178,
                    "end": 1197,
                    "text": "(Fried et al. 2002;",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 1198,
                    "end": 1222,
                    "text": "Hadziyannis et al. 2004;",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 1223,
                    "end": 1241,
                    "text": "Manns et al. 2001)",
                    "ref_id": "BIBREF123"
                },
                {
                    "start": 1396,
                    "end": 1415,
                    "text": "(Fried et al. 2002;",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 1416,
                    "end": 1440,
                    "text": "Hadziyannis et al. 2004;",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 1441,
                    "end": 1459,
                    "text": "Manns et al. 2001)",
                    "ref_id": "BIBREF123"
                },
                {
                    "start": 1635,
                    "end": 1654,
                    "text": "(Fried et al. 2002;",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 1655,
                    "end": 1679,
                    "text": "Hadziyannis et al. 2004;",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 1680,
                    "end": 1698,
                    "text": "Manns et al. 2001)",
                    "ref_id": "BIBREF123"
                }
            ],
            "ref_spans": [],
            "section": "IFN-\u03b1-Ribavirin Combination Therapy"
        },
        {
            "text": "Pegylated IFN-\u03b1-ribavirin combination therapy can be improved by increasing the dose of pegylated IFN-\u03b1 and/or ribavirin in selected patients and by tailoring the length of treatment to the virological response.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Optimized Pegylated IFN-\u03b1-Ribavirin Combination Therapy"
        },
        {
            "text": "The optimal dose of ribavirin is still uncertain. The approved dose is 0.8 g/day for patients infected with HCV genotypes 2 and 3, and 1.0-1.2 g/day in patients (weighting less and more than 75 kg, respectively) infected with HCV genotypes 1, 4, 5, and 6. However, several studies have suggested that higher serum ribavirin concentrations are associated with higher SVR rates (Jen et al. 2000 (Jen et al. , 2002 Lindahl et al. 2005) . In patients infected with HCV genotype 1, the probability of an SVR increases with the AUC of ribavirin concentrations (Snoeck et al. 2006 ). In addition, the proportion of patients achieving an SVR is higher with a standard weight-based dose of ribavirin than with a low dose . Although adverse effects are more frequent and more serious, the use of high ribavirin doses (average 2.5 g/day) to treat patients with high-viral-load HCV genotype 1 infection is feasible and leads to an SVR in 9 out of 10 patients (Lindahl et al. 2005 ). The use of higher ribavirin doses is offset by the potential increase in drug-related toxicity (principally hemolytic anemia), especially at doses above 15 mg/kg. Epoetin (or darbepoetin, an epoetin prodrug) can be used to reduce the incidence and severity of anemia. However, neither the FDA nor the EMEA has approved the use of these drugs in the treatment of chronic hepatitis C, and the cost-effectiveness of this approach has been questioned (McHutchison et al. 2007b ). In patients with HCV genotype 2 or 3 infection, the SVR rate is not strongly influenced by the dose of ribavirin, and 0.8 g/day is probably sufficient to maximize the chances of achieving an SVR (Fried et al. 2002; Hadziyannis et al. 2004; Manns et al. 2001) . Whether lower doses of ribavirin could be sufficient to achieve the same SVR rates is currently under investigation.",
            "cite_spans": [
                {
                    "start": 376,
                    "end": 392,
                    "text": "(Jen et al. 2000",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 393,
                    "end": 411,
                    "text": "(Jen et al. , 2002",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 412,
                    "end": 432,
                    "text": "Lindahl et al. 2005)",
                    "ref_id": "BIBREF117"
                },
                {
                    "start": 554,
                    "end": 573,
                    "text": "(Snoeck et al. 2006",
                    "ref_id": "BIBREF177"
                },
                {
                    "start": 947,
                    "end": 967,
                    "text": "(Lindahl et al. 2005",
                    "ref_id": "BIBREF117"
                },
                {
                    "start": 1418,
                    "end": 1443,
                    "text": "(McHutchison et al. 2007b",
                    "ref_id": "BIBREF130"
                },
                {
                    "start": 1642,
                    "end": 1661,
                    "text": "(Fried et al. 2002;",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 1662,
                    "end": 1686,
                    "text": "Hadziyannis et al. 2004;",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 1687,
                    "end": 1705,
                    "text": "Manns et al. 2001)",
                    "ref_id": "BIBREF123"
                }
            ],
            "ref_spans": [],
            "section": "Elevated Doses"
        },
        {
            "text": "In a so-called difficult-to-treat patient population (HCV RNA > 800,000 IU/ml and body weight > 85 kg), raising the doses of both pegylated IFN-\u03b1 and ribavirin significantly increased the SVR rate (Fried et al. 2006) . In another study, weightbased ribavirin administration up to 1.4 g/day was more effective than a fixed dose of 0.8 g/day in patients infected with HCV genotype 1 (Jacobson et al. 2005) . In a small number of cirrhotic patients infected with HCV genotype 1 who had not responded to a previous course of pegylated IFN-\u03b1 and ribavirin, 180 \u03bcg of pegylated IFN-\u03b12a every 5 days, combined with ribavirin, induced an SVR in several cases (H\u00e9zode et al. 2006) . Ongoing trials are assessing more frequent administration and higher weekly doses of pegylated IFN-\u03b1, and higher doses of ribavirin, in nonresponder and difficult-to-treat patients. Patients receiving such reinforced therapy must be carefully monitored for toxicity, and the merits and drawbacks of growth factor administration should be considered.",
            "cite_spans": [
                {
                    "start": 197,
                    "end": 216,
                    "text": "(Fried et al. 2006)",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 381,
                    "end": 403,
                    "text": "(Jacobson et al. 2005)",
                    "ref_id": "BIBREF85"
                },
                {
                    "start": 651,
                    "end": 671,
                    "text": "(H\u00e9zode et al. 2006)",
                    "ref_id": "BIBREF17"
                }
            ],
            "ref_spans": [],
            "section": "Elevated Doses"
        },
        {
            "text": "Current guidelines state that the length of treatment should be tailored to the HCV genotype (Pawlotsky 2006) . Patients infected with HCV genotypes 1, 4, 5, and 6 should be treated for 48 weeks (with 1.0-1.2 g/day ribavirin), whereas patients infected with HCV genotypes 2 and 3 should be treated for 24 weeks only (with 0.8 g/day ribavirin) Hadziyannis et al. 2004 ). Treatment must be stopped at week 12 in genotype 1-infected patients who do not have a 2-log drop in their HCV RNA level. Rapid virologic responses (RVR) are defined by an HCV RNA level below 50 IU/ml at week 4 of therapy. Several recent reports suggest that patients with an RVR could qualify for shorter treatment, which would improve adherence and reduce the cost of therapy. Conversely, extending treatment duration beyond 48 weeks may achieve an SVR in patients infected with HCV genotype 1 who have a slow virologic response, defined as an HCV RNA decline of more than 2 log IU/ml but a value above 50 IU/ml at week 12. For more detailed information, see the chapter by Zeuzem, this volume.",
            "cite_spans": [
                {
                    "start": 93,
                    "end": 109,
                    "text": "(Pawlotsky 2006)",
                    "ref_id": "BIBREF149"
                },
                {
                    "start": 343,
                    "end": 366,
                    "text": "Hadziyannis et al. 2004",
                    "ref_id": "BIBREF72"
                }
            ],
            "ref_spans": [],
            "section": "Tailoring the Treatment Duration to the Virological Response"
        },
        {
            "text": "HCV infection is rarely diagnosed in the acute phase, as most acutely infected individuals are asymptomatic. Between 50% and 90% of patients develop chronic infection, however, and this warrants early therapy. After occupational exposure with a known date, treatment should not be started before the acute episode characterized by alanine aminotransferase elevation, but it should always be started within 24 weeks after the onset of symptoms. The optimal treatment schedule for acute hepatitis C is controversial. Pegylated IFN-\u03b1 monotherapy at the standard dose for 24 weeks yielded SVR rates close to 100% in symptomatic patients referred to tertiary care centers (De Rosa et al. 2006; Jaeckel et al. 2001; Santantonio et al. 2005; Wiegand et al. 2006) . Shorter therapy may be envisaged (Calleri et al. 2007 ). Combination with ribavirin is recommended if a first course of pegylated IFN-\u03b1 monotherapy fails to eradicate the infection. Viral elimination appears to be independent of the HCV genotype and the HCV RNA level (Calleri et al. 2007; De Rosa et al. 2006; Jaeckel et al. 2001 ).",
            "cite_spans": [
                {
                    "start": 671,
                    "end": 688,
                    "text": "Rosa et al. 2006;",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 689,
                    "end": 709,
                    "text": "Jaeckel et al. 2001;",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 710,
                    "end": 734,
                    "text": "Santantonio et al. 2005;",
                    "ref_id": "BIBREF165"
                },
                {
                    "start": 735,
                    "end": 755,
                    "text": "Wiegand et al. 2006)",
                    "ref_id": "BIBREF194"
                },
                {
                    "start": 791,
                    "end": 811,
                    "text": "(Calleri et al. 2007",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 1026,
                    "end": 1047,
                    "text": "(Calleri et al. 2007;",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 1048,
                    "end": 1068,
                    "text": "De Rosa et al. 2006;",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 1069,
                    "end": 1088,
                    "text": "Jaeckel et al. 2001",
                    "ref_id": "BIBREF86"
                }
            ],
            "ref_spans": [],
            "section": "Treatment of Acute HCV Infection with IFN-\u03b1"
        },
        {
            "text": "Several studies have tested IFN-\u03b2 for chronic hepatitis C, achieving response rates similar to those obtained with IFN-\u03b1 and with similar or fewer adverse effects (Barbaro et al. 1999; Castro et al. 1997; Habersetzer et al. 2000; Montalto et al. 1998; Villa et al. 1996) . Recent reports from Japan suggest that daily IFN-\u03b2 administration is highly effective in patients with low or moderate HCV RNA levels (Horiike and Onji 2003; Shiratori et al. 2000) . Twice-daily administration of IFN-\u03b2 as induction therapy has also been reported to be effective Nakajima et al. 2003) . It is unlikely, however, that IFN-\u03b2 will be used in routine clinical practice unless it is pegylated or otherwise modified, and until specific clinical trials are done.",
            "cite_spans": [
                {
                    "start": 163,
                    "end": 184,
                    "text": "(Barbaro et al. 1999;",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 185,
                    "end": 204,
                    "text": "Castro et al. 1997;",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 205,
                    "end": 229,
                    "text": "Habersetzer et al. 2000;",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 230,
                    "end": 251,
                    "text": "Montalto et al. 1998;",
                    "ref_id": "BIBREF132"
                },
                {
                    "start": 252,
                    "end": 270,
                    "text": "Villa et al. 1996)",
                    "ref_id": "BIBREF189"
                },
                {
                    "start": 407,
                    "end": 430,
                    "text": "(Horiike and Onji 2003;",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 431,
                    "end": 453,
                    "text": "Shiratori et al. 2000)",
                    "ref_id": "BIBREF174"
                },
                {
                    "start": 552,
                    "end": 573,
                    "text": "Nakajima et al. 2003)",
                    "ref_id": "BIBREF136"
                }
            ],
            "ref_spans": [],
            "section": "Other IFNs"
        },
        {
            "text": "IFN-\u03c9 (Intarcia Therapeutics, Emeryville, California) has been reported to be well tolerated and safe, in patients infected with various HCV genotypes, at doses of 15-120 \u03bcg three times weekly for 12 weeks, with dose-dependent virological and biochemical responses (Plauth et al. 2002) . At a dose of 25 \u03bcg daily, IFN-\u03c9 induced a 2-log HCV RNA decline at week 12 in two-thirds of 74 patients infected with HCV genotype 1 (Gorbakov et al. 2005) . In a recent trial, SVR was achieved in 6% and 36% of patients receiving the same dose of IFN-\u03c9 without and with ribavirin, respectively (Novozhenov et al. 2007) . A new trial of IFN-\u03c9, delivered continuously by an implantable device, will start soon.",
            "cite_spans": [
                {
                    "start": 265,
                    "end": 285,
                    "text": "(Plauth et al. 2002)",
                    "ref_id": "BIBREF157"
                },
                {
                    "start": 421,
                    "end": 443,
                    "text": "(Gorbakov et al. 2005)",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 582,
                    "end": 606,
                    "text": "(Novozhenov et al. 2007)",
                    "ref_id": "BIBREF142"
                }
            ],
            "ref_spans": [],
            "section": "Other IFNs"
        },
        {
            "text": "IFN-\u03b3 has potent activity against HCV in the subgenomic replicon system (Dash et al. 2005; Frese et al. 2002; Lanford et al. 2003) . Synergistic immunomodulatory effects of IFN-\u03b31b and IFN-\u03b1 have been reported ). However, a pilot study of IFN-\u03b3 at a dose of 100-400 \u03bcg three times per week showed no antiviral efficacy in patients infected with HCV genotype 1 who had not responded to standard therapy or who had relapsed (Soza et al. 2005) .",
            "cite_spans": [
                {
                    "start": 72,
                    "end": 90,
                    "text": "(Dash et al. 2005;",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 91,
                    "end": 109,
                    "text": "Frese et al. 2002;",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 110,
                    "end": 130,
                    "text": "Lanford et al. 2003)",
                    "ref_id": "BIBREF107"
                },
                {
                    "start": 422,
                    "end": 440,
                    "text": "(Soza et al. 2005)",
                    "ref_id": "BIBREF180"
                }
            ],
            "ref_spans": [],
            "section": "Other IFNs"
        },
        {
            "text": "IFN-\u03bb1 exhibits dose-and time-dependent inhibition of HCV replication in various models, independently of type I and II IFN receptors and induced pathways (Marcello et al. 2006) . A pegylated form of IFN-\u03bb will soon enter clinical evaluation.",
            "cite_spans": [
                {
                    "start": 155,
                    "end": 177,
                    "text": "(Marcello et al. 2006)",
                    "ref_id": "BIBREF125"
                }
            ],
            "ref_spans": [],
            "section": "Other IFNs"
        },
        {
            "text": "Alb-IFN-\u03b12b has been reported to induce a dose-dependent antiviral response in previously untreated patients and in nonresponders to the pegylated IFN-\u03b1 and ribavirin combination (Bain et al. 2006; Balan et al. 2006) . The results of a phase II trial in untreated genotype 1-infected patients were recently reported: the SVR rates were not significantly different among four groups of patients receiving either the standard pegylated IFN-\u03b12a and ribavirin combination or alb-IFN-\u03b12b at doses of 900 \u03bcg every two weeks, 1,200 \u03bcg every 2 weeks and 1,200 \u03bcg every 4 weeks ). End-of-treatment responses to alb-IFN-\u03b12b administered every 2 or 4 weeks in combination with ribavirin are similarly frequent in patients infected with HCV genotypes 2 and 3 ). Higher doses of alb-IFN-\u03b12b given every 4 weeks are currently under investigation, and the product will soon enter phase III clinical evaluation.",
            "cite_spans": [
                {
                    "start": 179,
                    "end": 197,
                    "text": "(Bain et al. 2006;",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 198,
                    "end": 216,
                    "text": "Balan et al. 2006)",
                    "ref_id": "BIBREF8"
                }
            ],
            "ref_spans": [],
            "section": "New IFN-\u03b1 Molecules"
        },
        {
            "text": "Consensus IFN-\u03b1 has been used in various populations of HCV-infected patients but the published results are variable. Consensus IFN-\u03b1 gave a higher response rate than the combination of standard IFN-\u03b1 and ribavirin in patients who relapsed after standard IFN-\u03b1 monotherapy (Miglioresi et al. 2003) . In patients in whom the standard IFN-\u03b1-ribavirin combination failed, an SVR rate of approximately 30% was obtained with consensus IFN-\u03b1 (Bocher et al. 2006) . In contrast, an SVR was achieved in only 8% of patients who did not respond to standard IFN-\u03b12b plus ribavirin (Moskovitz et al. 2003) . Recently, a direct comparison of consensus IFN\u03b1-ribavirin and pegylated IFN-\u03b1-ribavirin showed similar SVR rates of 37% and 41%, respectively, in previously untreated patients infected with HCV genotype 1 (Sjogren et al. 2007 ). Nevertheless, there is no clear evidence that consensus IFN-\u03b1 is superior to other IFNs when given at equivalent doses. The future of consensus IFN-\u03b1 will depend on the development of a pegylated or otherwise pharmacologically modified form.",
            "cite_spans": [
                {
                    "start": 273,
                    "end": 297,
                    "text": "(Miglioresi et al. 2003)",
                    "ref_id": "BIBREF131"
                },
                {
                    "start": 436,
                    "end": 456,
                    "text": "(Bocher et al. 2006)",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 570,
                    "end": 593,
                    "text": "(Moskovitz et al. 2003)",
                    "ref_id": "BIBREF133"
                },
                {
                    "start": 801,
                    "end": 821,
                    "text": "(Sjogren et al. 2007",
                    "ref_id": "BIBREF176"
                }
            ],
            "ref_spans": [],
            "section": "New IFN-\u03b1 Molecules"
        },
        {
            "text": "The results of IFN-\u03b1-based therapy can theoretically be improved by using bettertolerated drugs that mimic the action of ribavirin and/or by using HCV inhibitors that, when combined, substantially reduce HCV replication. Since the mechanism of action of ribavirin is still unknown, no credible alternative approach is currently available. In contrast, many specific inhibitors of the HCV replication cycle are in preclinical development and several have reached clinical development (Pawlotsky et al. 2007) . A number of them are being tested in combination with pegylated IFN\u03b1, with or without ribavirin.",
            "cite_spans": [
                {
                    "start": 483,
                    "end": 506,
                    "text": "(Pawlotsky et al. 2007)",
                    "ref_id": "BIBREF150"
                }
            ],
            "ref_spans": [],
            "section": "Enhanced IFN-\u03b1-Based Therapy"
        },
        {
            "text": "The NS3/4A serine proteinase inhibitors telaprevir (VX-950, Vertex Pharmaceuticals, Cambridge, Massachusetts) and boceprevir (SCH 503034, Schering-Plough Corporation, Kenilworth, New Jersey) have now advanced to phase II clinical trials. In a recent trial, HCV RNA became undetectable (below 10 IU/ml) in all 12 patients receiving the triple combination of pegylated IFN-\u03b12a, ribavirin, and telaprevir for 28 days . Preliminary results of the PROVE 1 phase II trial showed that, after 12 weeks of treatment with telaprevir plus both pegylated IFN-\u03b1 and ribavirin, HCV RNA was undetectable (<10 IU/ml) in significantly more genotype 1-infected treatment-naive patients than in the arm receiving only the dual combination of pegylated IFN-\u03b1 and ribavirin, without telaprevir (70% and 39%, respectively). Telaprevir administration was associated with more frequent dermatological (especially rash and pruritus) and gastrointestinal side effects (McHutchison et al. 2007a) . Telaprevir was withdrawn after 12 weeks in all the groups, and the patients will continue on pegylated IFN-\u03b1 and ribavirin for various times. Other trials of the triple combination given for 12 or 24 weeks and a dual combination of pegylated IFN-\u03b1 and telaprevir (without ribavirin) are undergoing in treatment-naive and nonresponder patients (PROVE 2 and PROVE 3).",
            "cite_spans": [
                {
                    "start": 942,
                    "end": 968,
                    "text": "(McHutchison et al. 2007a)",
                    "ref_id": "BIBREF129"
                }
            ],
            "ref_spans": [],
            "section": "Enhanced IFN-\u03b1-Based Therapy"
        },
        {
            "text": "In nonresponders to IFN-\u03b1-ribavirin, the antiviral effect of boceprevir appeared to be strictly additive to that of pegylated IFN-\u03b12b (Sarrazin et al. 2007 ). In an ongoing phase II clinical trial, higher doses of boceprevir are being administered to treatment-naive patients, in combination with pegylated IFN-\u03b1 and ribavirin.",
            "cite_spans": [
                {
                    "start": 134,
                    "end": 155,
                    "text": "(Sarrazin et al. 2007",
                    "ref_id": "BIBREF169"
                }
            ],
            "ref_spans": [],
            "section": "Enhanced IFN-\u03b1-Based Therapy"
        },
        {
            "text": "Resistance is a problem when these drugs are administered alone and will need to be carefully monitored when they are used in combination with IFN-\u03b1 and ribavirin.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Enhanced IFN-\u03b1-Based Therapy"
        },
        {
            "text": "Inhibitors of the RNA-dependent RNA polymerase belong to two categories: nucleoside/nucleotide inhibitors target the catalytic site of the enzyme, and nonnucleoside inhibitors target allosteric sites of the RdRp (Pawlotsky et al. 2007) . Three RdRp inhibitors have been tested in clinical trials, including two nucleoside inhibitors, valopicitabine (NM283, Idenix Pharmaceuticals, Cambridge, Massachusetts, and Novartis) and R1626 (Roche), and a non-nucleoside inhibitor, HCV-796 (ViroPharma, Exton, Pennsylvania, and Wyeth Pharmaceuticals, Madison, New Jersey) (Pawlotsky et al. 2007) .",
            "cite_spans": [
                {
                    "start": 212,
                    "end": 235,
                    "text": "(Pawlotsky et al. 2007)",
                    "ref_id": "BIBREF150"
                },
                {
                    "start": 562,
                    "end": 585,
                    "text": "(Pawlotsky et al. 2007)",
                    "ref_id": "BIBREF150"
                }
            ],
            "ref_spans": [],
            "section": "Enhanced IFN-\u03b1-Based Therapy"
        },
        {
            "text": "In a phase IIb trial involving 190 HCV genotype-1-infected treatment-refractory patients, valopicitabine had a dose-dependent additive effect to that of pegylated IFN-\u03b12a (Afdhal et al. 2006) . Frequent gastrointestinal side-effects have been reported and the development of valopicitabine has been halted. In a phase II trial in which HCV genotype 1-and non-1-infected patients received the combination of pegylated IFN-\u03b12b and HCV-796 for 14 days, the HCV RNA level fell more than with pegylated IFN alone (3.3-3.5 log IU/ml in the combination groups and 1.6 log IU/ml in the pegylated IFN-\u03b1 group), and no viral breakthroughs due to resistance selection occurred during the 14 days of administration (Villano et al. 2007 ). R1626, combined with pegylated IFN alpha and ribavirin, has recently progressed to phase II clinical development. Further studies are needed to establish the potential benefits and drawbacks of adding HCV replication cycle inhibitors to the pegylated IFN-\u03b1-ribavirin combination, the current standard of care.",
            "cite_spans": [
                {
                    "start": 171,
                    "end": 191,
                    "text": "(Afdhal et al. 2006)",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 703,
                    "end": 723,
                    "text": "(Villano et al. 2007",
                    "ref_id": "BIBREF190"
                }
            ],
            "ref_spans": [],
            "section": "Enhanced IFN-\u03b1-Based Therapy"
        },
        {
            "text": "HBV-infected patients can be subdivided into two groups according to the presence or absence of circulating hepatitis B e (HBe) antigen (Ag). HBeAg-negative patients do not produce HBeAg because the infecting virus harbors precore and/or core promoter nucleotide substitutions (Carman et al. 1989 ). They generally have lower, fluctuating HBV DNA levels and a more severe course of disease. Chronic HBV infection currently is not curable, because covalently closed circular DNA (cc-cDNA) persists in the hepatocyte nucleus. Antiviral treatment of chronic hepatitis B has a triple aim: (1) to slow the progression of fibrosis to cirrhosis; (2) to prevent hepatic failure; and (3) to prevent hepatocellular carcinoma. Profound and sustained inhibition of HBV replication is necessary if these goals are to be achieved. Treatment can consist of short-term therapy, generally with IFN-\u03b1, or long-term (possibly life-long) therapy with specific nucleoside/nucleotide analogue inhibitors of HBV replication.",
            "cite_spans": [
                {
                    "start": 277,
                    "end": 296,
                    "text": "(Carman et al. 1989",
                    "ref_id": "BIBREF21"
                }
            ],
            "ref_spans": [],
            "section": "IFN-Based Treatment of Hepatitis B Virus Infection"
        },
        {
            "text": "The virological response, which is assessed by measuring HBV DNA levels in serum during and after therapy, is the best predictor of the outcome of antiviral treatment. It has been suggested that HBV viral load should be reduced to less than 2,000 IU/mL (de Franchis et al. 2003; Keeffe et al. 2006; Liaw et al. 2005; Lok and McMahon 2007) , but the ideal outcome is undetectable HBV DNA (< 10-30 IU/ml) in highly sensitive real-time PCR-based assays. In HBeAg-positive patients, loss of HBeAg followed by the emergence of anti-HBe antibodies (\"e\" seroconversion) indicates a sustained response to therapy when it persists after treatment cessation. HBs seroconversion (loss of HBsAg and emergence of anti-HBs antibodies) is the most desirable endpoint, as it indicates a complete response with sustained remission from HBV disease. It is rarely achieved with current therapies.",
            "cite_spans": [
                {
                    "start": 253,
                    "end": 278,
                    "text": "(de Franchis et al. 2003;",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 279,
                    "end": 298,
                    "text": "Keeffe et al. 2006;",
                    "ref_id": "BIBREF99"
                },
                {
                    "start": 299,
                    "end": 316,
                    "text": "Liaw et al. 2005;",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 317,
                    "end": 338,
                    "text": "Lok and McMahon 2007)",
                    "ref_id": "BIBREF119"
                }
            ],
            "ref_spans": [],
            "section": "IFN-Based Treatment of Hepatitis B Virus Infection"
        },
        {
            "text": "IFN-\u03b1 was first used empirically in chronic hepatitis B in 1986 ). The effect of human recombinant IFN-\u03b1 on lymphocyte proliferation and differentiation was studied in 18 patients with chronic hepatitis B. Inhibition of immunoglobulin synthesis was observed, and the authors postulated that the immunomodulatory effect of IFN-\u03b1 could be important in the therapeutic response of chronic hepatitis B ). The first study to evaluate the antiviral efficacy of IFN-\u03b1 involved nine patients, who received different doses administered three times a week for two weeks. Two of them entered sustained remission, with undetectable HBV DNA, loss of HBeAg, and ALT normalization (Dooley et al. 1986 ). Two forms of IFN-\u03b1 have been used in the treatment of chronic hepatitis B, namely standard and pegylated IFN-\u03b1.",
            "cite_spans": [
                {
                    "start": 666,
                    "end": 685,
                    "text": "(Dooley et al. 1986",
                    "ref_id": "BIBREF38"
                }
            ],
            "ref_spans": [],
            "section": "Treatment of Chronic HBV Infection with IFN-\u03b1"
        },
        {
            "text": "Standard IFN-\u03b1 has been used in chronic HBV infection at a dose of 5 million units (MU) daily or 9-10 MU three times a week (de Franchis et al. 2003) . A 4-to 6-month course was initially recommended, but it soon appeared that longer treatment (12 months or more) could result in more frequent and more durable responses (Hui et al. 2006; Lampertico et al. 1997; Lampertico et al. 2003) .",
            "cite_spans": [
                {
                    "start": 124,
                    "end": 149,
                    "text": "(de Franchis et al. 2003)",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 321,
                    "end": 338,
                    "text": "(Hui et al. 2006;",
                    "ref_id": "BIBREF82"
                },
                {
                    "start": 339,
                    "end": 362,
                    "text": "Lampertico et al. 1997;",
                    "ref_id": "BIBREF104"
                },
                {
                    "start": 363,
                    "end": 386,
                    "text": "Lampertico et al. 2003)",
                    "ref_id": "BIBREF105"
                }
            ],
            "ref_spans": [],
            "section": "Standard IFN-\u03b1 Monotherapy"
        },
        {
            "text": "A meta-analysis of 15 randomized controlled trials involving HBeAg-positive patients showed that, after 12-24 weeks of treatment, HBeAg was lost in 33% of cases, with HBe seroconversion in 18% of them, compared to 12% in the control arm (Wong et al. 1993) . HBeAg relapsed in 10-30% of patients who received the shortest treatments (Lau et al. 1997; Lok et al. 1993; Niederau et al. 1996; van Zonneveld et al. 2004 ). Clearance of HBsAg and seroconversion to anti-HBs antibodies were rare and occurred late (5-10% of patients 1 year after treatment in European studies). HBsAg was lost in 11-25% of sustained HBe seroconverters after 5 years (Bortolotti et al. 2000; Fattovich et al. 1998; Niederau et al. 1996) .",
            "cite_spans": [
                {
                    "start": 237,
                    "end": 255,
                    "text": "(Wong et al. 1993)",
                    "ref_id": "BIBREF196"
                },
                {
                    "start": 332,
                    "end": 349,
                    "text": "(Lau et al. 1997;",
                    "ref_id": "BIBREF108"
                },
                {
                    "start": 350,
                    "end": 366,
                    "text": "Lok et al. 1993;",
                    "ref_id": "BIBREF120"
                },
                {
                    "start": 367,
                    "end": 388,
                    "text": "Niederau et al. 1996;",
                    "ref_id": "BIBREF138"
                },
                {
                    "start": 389,
                    "end": 414,
                    "text": "van Zonneveld et al. 2004",
                    "ref_id": "BIBREF186"
                },
                {
                    "start": 642,
                    "end": 666,
                    "text": "(Bortolotti et al. 2000;",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 667,
                    "end": 689,
                    "text": "Fattovich et al. 1998;",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 690,
                    "end": 711,
                    "text": "Niederau et al. 1996)",
                    "ref_id": "BIBREF138"
                }
            ],
            "ref_spans": [],
            "section": "HBeAg-Positive Patients"
        },
        {
            "text": "Standard IFN-\u03b1 treatment has been shown to reduce the risk of cirrhosis and hepatocellular carcinoma ).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HBeAg-Positive Patients"
        },
        {
            "text": "The use of IFN-\u03b1-based therapy is more controversial in HBeAg-negative patients, in whom sustained responses such as HBe seroconversion cannot be expected. Four randomized controlled trials showed a reduction in the HBV DNA level at the end of treatment in 60-70% of patients, compared to 10-20% of untreated controls (Fattovich et al. 2000; Lampertico et al. 1997; Manesis and Hadziyannis 2001; Pastore et al. 1992) . However, about half the virological responders relapsed after treatment discontinuation, and relapses continued to occur for up to 5 years posttherapy (Papatheodoridis et al. 2001) . Despite the high relapse rates, a sustained virological response (sustained inhibition of viral replication) was achieved in about one-third of patients 5 years after treatment (Kaymakoglu et al. 2007a) . Longer IFN treatment periods (12 months or more) are associated with higher rates of sustained virological response (Lampertico et al. 1997 (Lampertico et al. , 2003 .",
            "cite_spans": [
                {
                    "start": 318,
                    "end": 341,
                    "text": "(Fattovich et al. 2000;",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 342,
                    "end": 365,
                    "text": "Lampertico et al. 1997;",
                    "ref_id": "BIBREF104"
                },
                {
                    "start": 366,
                    "end": 395,
                    "text": "Manesis and Hadziyannis 2001;",
                    "ref_id": "BIBREF122"
                },
                {
                    "start": 396,
                    "end": 416,
                    "text": "Pastore et al. 1992)",
                    "ref_id": "BIBREF148"
                },
                {
                    "start": 570,
                    "end": 599,
                    "text": "(Papatheodoridis et al. 2001)",
                    "ref_id": "BIBREF146"
                },
                {
                    "start": 779,
                    "end": 804,
                    "text": "(Kaymakoglu et al. 2007a)",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 923,
                    "end": 946,
                    "text": "(Lampertico et al. 1997",
                    "ref_id": "BIBREF104"
                },
                {
                    "start": 947,
                    "end": 972,
                    "text": "(Lampertico et al. , 2003",
                    "ref_id": "BIBREF105"
                }
            ],
            "ref_spans": [],
            "section": "HBeAg-Negative Patients"
        },
        {
            "text": "Two small studies of repeat therapy with standard IFN-\u03b1 involved both HBeAgpositive and HBeAg-negative patients (Carreno et al. 1999; Manesis and Hadziyannis 2001) . Retreatment of nonresponders and responder-relapsers resulted in sustained virological responses in 33% and 35% of cases, respectively. However, the results were difficult to interpret, as the first IFN-\u03b1 dose regimen and the interval before retreatment were both variable.",
            "cite_spans": [
                {
                    "start": 112,
                    "end": 133,
                    "text": "(Carreno et al. 1999;",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 134,
                    "end": 163,
                    "text": "Manesis and Hadziyannis 2001)",
                    "ref_id": "BIBREF122"
                }
            ],
            "ref_spans": [],
            "section": "Retreatment of nonresponders with standard IFN-\u03b1"
        },
        {
            "text": "Pegylated IFN-\u03b12a, but not pegylated IFN-\u03b12b, has been approved by the American and European authorities for the treatment of chronic hepatitis B, based on two large pivotal trials involving HBeAg-postive and HBeAg-negative patients Marcellin et al. 2004) . Pegylated IFN-\u03b12b has also been tested in HBeAg-positive and HBeAg-negative patients (Flink et al. 2006b; Janssen et al. 2005; Kaymakoglu et al. 2007b; Zhao et al. 2007 ).",
            "cite_spans": [
                {
                    "start": 233,
                    "end": 255,
                    "text": "Marcellin et al. 2004)",
                    "ref_id": "BIBREF124"
                },
                {
                    "start": 343,
                    "end": 363,
                    "text": "(Flink et al. 2006b;",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 364,
                    "end": 384,
                    "text": "Janssen et al. 2005;",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 385,
                    "end": 409,
                    "text": "Kaymakoglu et al. 2007b;",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 410,
                    "end": 426,
                    "text": "Zhao et al. 2007",
                    "ref_id": "BIBREF202"
                }
            ],
            "ref_spans": [],
            "section": "Pegylated IFN-\u03b1 Monotherapy"
        },
        {
            "text": "In a clinical phase II trial, the efficacy of various doses of pegylated IFN-\u03b12a (90-270 \u03bcg weekly) administered for 24 weeks was studied in treatment-na\u00efve patients, by comparison with standard IFN-\u03b12a at a dose of 4.5 MU three times a week (Cooksley et al. 2003) . At the end of follow-up, 24 weeks after the end of therapy, HBeAg had been lost by 35% of patients receiving pegylated IFN-\u03b12a 180 \u03bcg weekly and by 25% of patients receiving standard IFN-\u03b1. In addition, an endpoint combining HBeAg loss, HBV DNA < 5.0 \u00d7 10 6 (6.7 log 10 copies/mL), and ALT normalization was reached by 24% of pegylated IFN-\u03b1-treated patients, whatever the dose regimen, compared to 12% of patients receiving standard IFN-\u03b1 (Cooksley et al. 2003) . A larger clinical trial tested pegylated IFN-\u03b12a monotherapy at a weekly dose of 180 \u03bcg . At the end of follow-up, HBeAg seroconversion had occurred in 32% of the patients and ALT had normalized in 41% of patients. The approved pegylated IFN-\u03b12a treatment schedule for HBeAg-positive patients is currently 180 \u03bcg weekly for 48 weeks. It is possible, however, that a lower dose and/or shorter treatment may be sufficient (Zhao et al. 2007) , and further studies are therefore needed (Hui et al. 2006) . With pegylated IFN-\u03b12b, 52 weeks of therapy yielded a 29% seroconversion rate 24 weeks after the end of treatment (Janssen et al. 2005) .",
            "cite_spans": [
                {
                    "start": 242,
                    "end": 264,
                    "text": "(Cooksley et al. 2003)",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 707,
                    "end": 729,
                    "text": "(Cooksley et al. 2003)",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 1152,
                    "end": 1170,
                    "text": "(Zhao et al. 2007)",
                    "ref_id": "BIBREF202"
                },
                {
                    "start": 1214,
                    "end": 1231,
                    "text": "(Hui et al. 2006)",
                    "ref_id": "BIBREF82"
                },
                {
                    "start": 1348,
                    "end": 1369,
                    "text": "(Janssen et al. 2005)",
                    "ref_id": "BIBREF88"
                }
            ],
            "ref_spans": [],
            "section": "HBeAg-Positive Patients"
        },
        {
            "text": "Several recent studies have suggested that the HBV genotype influences treatment outcome, HBV genotype A or B infection tending to respond better to pegylated IFN-\u03b1 than HBV genotype C or D infection (Flink et al. 2006b; Janssen et al. 2005; Zhao et al. 2007 ). However, more data are needed before using the HBV genotype to tailor treatment.",
            "cite_spans": [
                {
                    "start": 200,
                    "end": 220,
                    "text": "(Flink et al. 2006b;",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 221,
                    "end": 241,
                    "text": "Janssen et al. 2005;",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 242,
                    "end": 258,
                    "text": "Zhao et al. 2007",
                    "ref_id": "BIBREF202"
                }
            ],
            "ref_spans": [],
            "section": "HBeAg-Positive Patients"
        },
        {
            "text": "One large trial evaluated 48 weeks of treatment with pegylated IFN-\u03b12a in HBeAgnegative patients . After 24 weeks of follow-up, 36% of the patients had normal ALT levels and HBV DNA levels below 20,000 copies/mL. HBsAg was lost in 4% of cases. In a trial of pegylated IFN-\u03b12b given for 48 weeks, 26% of patients achieved an HBV DNA level below 400 copies/mL (Kaymakoglu et al. 2007b ).",
            "cite_spans": [
                {
                    "start": 358,
                    "end": 382,
                    "text": "(Kaymakoglu et al. 2007b",
                    "ref_id": "BIBREF97"
                }
            ],
            "ref_spans": [],
            "section": "HBeAg-Negative Patients"
        },
        {
            "text": "In two published cohort studies, pegylated IFN-\u03b1 was effective in approximately one-third of HBeAg-positive patients in whom standard IFN-\u03b1 or lamivudine had failed (Flink et al. 2006a; Leemans et al. 2006 ).",
            "cite_spans": [
                {
                    "start": 165,
                    "end": 185,
                    "text": "(Flink et al. 2006a;",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 186,
                    "end": 205,
                    "text": "Leemans et al. 2006",
                    "ref_id": "BIBREF113"
                }
            ],
            "ref_spans": [],
            "section": "Nonresponders to Standard IFN-\u03b1 and Lamivudine"
        },
        {
            "text": "A few studies have evaluated standard IFN-\u03b12a and -\u03b12b combined with lamivudine, whereas more recent trials tested pegylated IFN-\u03b1 combined with nucleoside/nucleotide analogues. The aim was to determine whether combination therapy could increase antiviral efficacy, reduce adverse effects, and hinder the emergence of analogue-resistant viral variants. Simultaneous and sequential protocols were both tested.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Combination Therapy with IFN-\u03b1 Alpha and Nucleoside/Nucleotide Analogues"
        },
        {
            "text": "Several studies have tested lamivudine and standard IFN-\u03b1 given simultaneously for 16-24 or 48-52 weeks. In one trial, involving HBeAg-positive patients, sustained HBe seroconversion and undetectable HBV DNA (<1.6 pg/mL) were significantly more frequent at the end of follow-up in patients receiving the combination than in patients treated with lamivudine alone (33% and 15%, respectively) (Barbaro et al. 2001) . In contrast, lamivudine plus standard IFN-\u03b1 was not more effective than lamivudine alone in HBeAg-negative patients (Akarca et al. 2004; Yurdaydin et al. 2005) . The incidence of lamivudine resistance was nonetheless lower when IFN-\u03b1 was coadministered (Jang et al. 2004; Santantonio et al. 2002) .",
            "cite_spans": [
                {
                    "start": 391,
                    "end": 412,
                    "text": "(Barbaro et al. 2001)",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 531,
                    "end": 551,
                    "text": "(Akarca et al. 2004;",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 552,
                    "end": 574,
                    "text": "Yurdaydin et al. 2005)",
                    "ref_id": "BIBREF199"
                },
                {
                    "start": 668,
                    "end": 686,
                    "text": "(Jang et al. 2004;",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 687,
                    "end": 711,
                    "text": "Santantonio et al. 2002)",
                    "ref_id": "BIBREF164"
                }
            ],
            "ref_spans": [],
            "section": "Simultaneous Combination Therapy"
        },
        {
            "text": "Conflicting results have been reported with pegylated IFN-\u03b1 and lamivudine combination therapy. In a randomized controlled trial involving HBeAg-positive patients, a sustained virological response (HBV DNA < 500,000 copies/mL) and HBe seroconversion were more frequent in patients receiving pegylated IFN-\u03b12b 1.5 \u03bcg/kg/week and lamivudine 100 mg daily than in patients receiving lamivudine monotherapy (Chan et al. 2005a, b) . In contrast, there was no difference in the rate of ALT normalization or histological improvement. Lamivudine resistance was more frequent with lamivudine monotherapy than with combination therapy (40% and 21% of patients, respectively). Another trial involving HBeAg-positive patients favored pegylated IFN-\u03b12a or -\u03b12b plus lamivudine over lamivudine monotherapy, but not over pegylated IFN-\u03b1 monotherapy, despite an additive antiviral effect . In another study involving HBeAgpositive patients, 52 weeks of treatment with pegylated IFN-\u03b12b yielded an HBe seroconversion rate of 29%, whether IFN-\u03b12b was given alone or combined with lamivudine (Janssen et al. 2005) . The combination did not improve liver histological status (van Zonneveld et al. 2006 ), but it induced less resistance to lamivudine. In HBeAg-negative patients, lamivudine combination with pegylated IFN-\u03b12a or -\u03b12b did not improve the rate of ALT normalization or HBV DNA suppression at the end of follow-up compared to pegylated IFN-\u03b1 alone. Nevertheless, the decline in viral load was more pronounced and lamivudine resistance was less frequent with the combination (Kaymakoglu et al. 2007b; Marcellin et al. 2004) .",
            "cite_spans": [
                {
                    "start": 402,
                    "end": 424,
                    "text": "(Chan et al. 2005a, b)",
                    "ref_id": null
                },
                {
                    "start": 1072,
                    "end": 1093,
                    "text": "(Janssen et al. 2005)",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 1154,
                    "end": 1180,
                    "text": "(van Zonneveld et al. 2006",
                    "ref_id": "BIBREF187"
                },
                {
                    "start": 1565,
                    "end": 1590,
                    "text": "(Kaymakoglu et al. 2007b;",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 1591,
                    "end": 1613,
                    "text": "Marcellin et al. 2004)",
                    "ref_id": "BIBREF124"
                }
            ],
            "ref_spans": [],
            "section": "Simultaneous Combination Therapy"
        },
        {
            "text": "One trial assessed the combination of pegylated IFN-\u03b12b and adefovir dipivoxil given for 48 weeks to both HBeAg-positive and HBeAg-negative patients. There was no control arm. Both liver cccDNA and serum HBsAg levels fell strongly, and 4 (17%) of the 26 patients seroconverted to anti-HBs at the end of follow-up (Wursthorn et al. 2006) .",
            "cite_spans": [
                {
                    "start": 313,
                    "end": 336,
                    "text": "(Wursthorn et al. 2006)",
                    "ref_id": "BIBREF197"
                }
            ],
            "ref_spans": [],
            "section": "Simultaneous Combination Therapy"
        },
        {
            "text": "The use of sequential combination therapy is based on the notion that lowering the HBV DNA level with nucleoside/nucleotide analogues, thereby permitting partial immune recovery, might improve the subsequent efficacy of pegylated IFN-\u03b1. One trial compared 8 weeks of lamivudine monotherapy followed by 16 weeks of lamivudine/standard IFN-\u03b1 combination therapy, with 52 weeks of lamivudine monotherapy in HBeAg-positive patients (Sarin et al. 2005) . The rate of sustained virological responses, defined by HBe seroconversion and undetectable HBV DNA (<1.4 \u00d7 10 5 copies/mL) 24 weeks after the end of treatment, was significantly higher with the combination than with lamivudine monotherapy. A recent study of HBeAg-positive patients conducted by the same group compared 4 weeks of lamivudine monotherapy followed by 24 weeks of pegylated IFN-\u03b1 therapy with 24 weeks of pegylated IFN-\u03b1 monotherapy (Sarin et al. 2007) . Six months after the end of treatment, HBV DNA was undetectable (below 4,700 copies/mL) in 50% of the patients who received sequential therapy and 15% of patients on pegylated IFN-\u03b1 monotherapy. HBeAg loss was also more frequent in the sequential therapy group (39% vs. 15%, respectively) (Sarin et al. 2007 ).",
            "cite_spans": [
                {
                    "start": 428,
                    "end": 447,
                    "text": "(Sarin et al. 2005)",
                    "ref_id": "BIBREF167"
                },
                {
                    "start": 897,
                    "end": 916,
                    "text": "(Sarin et al. 2007)",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 1208,
                    "end": 1226,
                    "text": "(Sarin et al. 2007",
                    "ref_id": "BIBREF168"
                }
            ],
            "ref_spans": [],
            "section": "Sequential Combination Therapy"
        },
        {
            "text": "In HBeAg-negative patients, 12 weeks of lamivudine monotherapy followed by 36 months of pegylated IFN-\u03b12b therapy (including 3 months of concomitant administration) has been compared with 48 weeks of lamivudine monotherapy (Vassiliadis et al. 2007) . At the end of follow-up, the rate of ALT normalization was significantly higher with the sequential therapy than with lamivudine alone. No difference in the proportion of patients with undetectable HBV DNA was observed. Similar results were obtained in a Chinese cohort study (Shi et al. 2006 ).",
            "cite_spans": [
                {
                    "start": 223,
                    "end": 248,
                    "text": "(Vassiliadis et al. 2007)",
                    "ref_id": "BIBREF188"
                },
                {
                    "start": 527,
                    "end": 543,
                    "text": "(Shi et al. 2006",
                    "ref_id": "BIBREF173"
                }
            ],
            "ref_spans": [],
            "section": "Sequential Combination Therapy"
        },
        {
            "text": "The antiviral efficacy of IFN-\u03b2 administered for 24 weeks at a dose of 3 million units daily has been studied in a small series of HBeAg-positive patients. HBe seroconversion was observed in half the patients and ALT normalization in four patients out of five (Kagawa et al. 1993) . Sequential therapy with lamivudine and IFN-\u03b2 has been tested in HBeAg-positive patients (Enomoto et al. 2007) . A sustained virological response was achieved in only 7 (29%) of the 24 patients, 24 weeks after the end of therapy. In a pilot study of IFN-\u03b2 therapy in 29 patients in whom IFN-\u03b1 therapy had failed, HBV DNA became undetectable in 6 patients (21%) (Munoz et al. 2002) .",
            "cite_spans": [
                {
                    "start": 260,
                    "end": 280,
                    "text": "(Kagawa et al. 1993)",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 371,
                    "end": 392,
                    "text": "(Enomoto et al. 2007)",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 643,
                    "end": 662,
                    "text": "(Munoz et al. 2002)",
                    "ref_id": "BIBREF134"
                }
            ],
            "ref_spans": [],
            "section": "Standard IFN-\u03b2 Monotherapy"
        },
        {
            "text": "The antiviral efficacy of IFN-\u03bb has been evaluated in vitro in human hepatocytederived cells. IFN-\u03bb reduced HBV replication but the results suggested that antiviral efficacy in vivo would be limited (Hong et al. 2007 ).",
            "cite_spans": [
                {
                    "start": 199,
                    "end": 216,
                    "text": "(Hong et al. 2007",
                    "ref_id": "BIBREF79"
                }
            ],
            "ref_spans": [],
            "section": "Standard IFN-\u03bb"
        },
        {
            "text": "IFN-\u03b3 exhibits antiviral activity against HBV in vitro (Parvez et al. 2006) . In addition, IFN-\u03b3 was found to reduce hepatic fibrosis by 63% after 9 months, compared to 24% in untreated controls (Weng et al. 2005) .",
            "cite_spans": [
                {
                    "start": 55,
                    "end": 75,
                    "text": "(Parvez et al. 2006)",
                    "ref_id": "BIBREF147"
                },
                {
                    "start": 195,
                    "end": 213,
                    "text": "(Weng et al. 2005)",
                    "ref_id": "BIBREF192"
                }
            ],
            "ref_spans": [],
            "section": "Treatment of Chronic HBV Infection with Type II IFN"
        },
        {
            "text": "Worldwide, 15 million HBsAg carriers are also infected with hepatitis D/delta virus (HDV) (Gaeta et al. 2000) . This situation represents a major therapeutic challenge, as most of these patients have advanced liver disease, including cirrhosis in 60-70% of cases, and hepatocellular carcinoma (Fattovich et al. 2000; Saracco et al. 1987) . No specific HDV inhibitors have been developed, and IFN-\u03b1-based treatment is more difficult in HBV-HDV infection than in HBV monoinfection. HDV RNA levels in serum can be used to monitor treatment efficacy. The endpoint of therapy is HDV RNA clearance and ALT normalization, and this is sometimes achieved after the end of treatment. A sustained response can lead to HBsAg clearance from serum.",
            "cite_spans": [
                {
                    "start": 90,
                    "end": 109,
                    "text": "(Gaeta et al. 2000)",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 293,
                    "end": 316,
                    "text": "(Fattovich et al. 2000;",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 317,
                    "end": 337,
                    "text": "Saracco et al. 1987)",
                    "ref_id": "BIBREF166"
                }
            ],
            "ref_spans": [],
            "section": "IFN-Based Treatment of Hepatitis D/Delta Virus Infection"
        },
        {
            "text": "To date, standard IFN-\u03b1, but not pegylated IFN-\u03b1, has been approved by the American and European authorities for the treatment of chronic hepatitis D. Clinical pilot trials conducted in the early 1990s suggested that IFN-\u03b1 could inhibit HDV replication. The sustainability of this inhibition depended on the dose and duration of IFN-\u03b1 therapy, and relapse was frequent (Farci et al. 1994; Gaudin et al. 1995; Madejon et al. 1994; Rosina et al. 1991) . A complete response, characterized by normalization of ALT levels and undetectable HDV RNA, was observed six months after the end of treatment in 50% of patients receiving a high dose of standard IFN\u03b1, compared to 21% and 0% of patients receiving a low dose of IFN-\u03b1 and no treatment, respectively ). IFN-\u03b1 treatment has been shown to provide a clinical benefit, with regression of advanced hepatic fibrosis. No pretreatment characteristics have been shown to predict the response to IFN-\u03b1, and the possible influence of the HDV genotype on the response is not known (Niro et al. 2005b ).",
            "cite_spans": [
                {
                    "start": 369,
                    "end": 388,
                    "text": "(Farci et al. 1994;",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 389,
                    "end": 408,
                    "text": "Gaudin et al. 1995;",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 409,
                    "end": 429,
                    "text": "Madejon et al. 1994;",
                    "ref_id": "BIBREF121"
                },
                {
                    "start": 430,
                    "end": 449,
                    "text": "Rosina et al. 1991)",
                    "ref_id": "BIBREF162"
                },
                {
                    "start": 1019,
                    "end": 1037,
                    "text": "(Niro et al. 2005b",
                    "ref_id": "BIBREF140"
                }
            ],
            "ref_spans": [],
            "section": "Standard IFN-\u03b1 Monotherapy"
        },
        {
            "text": "Several strategies have been developed to improve the efficacy of standard IFN-\u03b1 treatment; in particular, treatment has been prolonged, for up to 12 years, but tolerability was poor (Lau et al. 1999b) .",
            "cite_spans": [
                {
                    "start": 183,
                    "end": 201,
                    "text": "(Lau et al. 1999b)",
                    "ref_id": "BIBREF111"
                }
            ],
            "ref_spans": [],
            "section": "Standard IFN-\u03b1 Monotherapy"
        },
        {
            "text": "Three recent studies evaluated the efficacy and safety of pegylated IFN-\u03b1 monotherapy in patients with HBV-HDV infection (Castelnau et al. 2006; Erhardt et al. 2006; Niro et al. 2006 ). The first tested was pegylated IFN-\u03b12b, given for 48 weeks to 14 patients. A virological response, defined by undetectable HDV RNA, was achieved in 43% of patients. ALT normalization was more frequent at the end of follow-up than at the end of therapy (Castelnau et al. 2006 ). The second study, a randomized controlled trial, evaluated the efficacy of 72 weeks of pegylated IFN-\u03b12b therapy. A virological response was achieved in 25% of patients (Niro et al. 2006 ). The last study assessed the efficacy and safety of 48 weeks of pegylated IFN-\u03b12b administration in 12 patients. A sustained virological response, defined by undetectable HDV RNA and ALT normalization, occurred in only 2 patients (17%) ). The different rates of sustained virological response might be explained by different frequencies of cirrhosis in the three study populations.",
            "cite_spans": [
                {
                    "start": 121,
                    "end": 144,
                    "text": "(Castelnau et al. 2006;",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 145,
                    "end": 165,
                    "text": "Erhardt et al. 2006;",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 166,
                    "end": 182,
                    "text": "Niro et al. 2006",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 438,
                    "end": 460,
                    "text": "(Castelnau et al. 2006",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 633,
                    "end": 650,
                    "text": "(Niro et al. 2006",
                    "ref_id": "BIBREF141"
                }
            ],
            "ref_spans": [],
            "section": "Pegylated IFN-\u03b1 Monotherapy"
        },
        {
            "text": "Drugs such as ribavirin that may directly reduce HDV replication and specific inhibitors of HBV replication such as lamivudine and adefovir dipivoxil have been tested in combination with IFN-\u03b1 in patients with chronic hepatitis D.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "IFN-\u03b1 Combination with Nucleoside/Nucleotide Analogues"
        },
        {
            "text": "Ribavirin inhibits HDV replication in hepatocyte cultures (Di Bisceglie 1997) . However, ribavirin monotherapy is not effective in patients with chronic hepatitis D. A pilot study evaluated the efficacy of ribavirin, 15 mg/kg, administered for 16 weeks to 9 patients. At the end of follow-up, HDV RNA levels were reduced in only one patient and ALT levels never normalized (Garripoli et al. 1994) . The efficacy of standard IFN-\u03b1, 9-10 MU three times a week, combined with ribavirin, 1,000-1,200 mg daily, has been evaluated in two studies each lasting 24 months (Gunsar et al. 2005; Kaymakoglu et al. 2005 ). Ribavirin did not increase the efficacy of IFN-\u03b1. Another trial tested the efficacy of a 72-week course of pegylated IFN-\u03b12b alone vs. 48 weeks of pegylated IFN-\u03b12b plus ribavirin followed by 24 weeks of pegylated IFN-\u03b12b alone. A virological response was achieved in 25% and 18% of patients, respectively, while the rates of biochemical response were similar (Niro et al. 2006) .",
            "cite_spans": [
                {
                    "start": 62,
                    "end": 77,
                    "text": "Bisceglie 1997)",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 373,
                    "end": 396,
                    "text": "(Garripoli et al. 1994)",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 563,
                    "end": 583,
                    "text": "(Gunsar et al. 2005;",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 584,
                    "end": 606,
                    "text": "Kaymakoglu et al. 2005",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 970,
                    "end": 988,
                    "text": "(Niro et al. 2006)",
                    "ref_id": "BIBREF141"
                }
            ],
            "ref_spans": [],
            "section": "Standard IFN-\u03b1 Plus Ribavirin"
        },
        {
            "text": "Thus, ribavirin is ineffective in chronic hepatitis D, whether given alone or in combination with IFN-\u03b1.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Standard IFN-\u03b1 Plus Ribavirin"
        },
        {
            "text": "Lamivudine monotherapy has no effect on HDV (Lau et al. 1999a; Niro et al. 2005a) , and lamivudine adjunction only slightly improves the efficacy of standard IFN-\u03b1 (Canbakan et al. 2006; Wolters et al. 2000) .",
            "cite_spans": [
                {
                    "start": 44,
                    "end": 62,
                    "text": "(Lau et al. 1999a;",
                    "ref_id": "BIBREF110"
                },
                {
                    "start": 63,
                    "end": 81,
                    "text": "Niro et al. 2005a)",
                    "ref_id": "BIBREF139"
                },
                {
                    "start": 164,
                    "end": 186,
                    "text": "(Canbakan et al. 2006;",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 187,
                    "end": 207,
                    "text": "Wolters et al. 2000)",
                    "ref_id": "BIBREF195"
                }
            ],
            "ref_spans": [],
            "section": "Standard IFN-\u03b1 Plus Lamivudine"
        },
        {
            "text": "A recent randomized multicenter trial compared the efficacy of pegylated IFN-\u03b12a monotherapy, adefovir monotherapy, and the pegylated IFN-\u03b12a/adefovir combination administered for 48 weeks to patients with chronic hepatitis D. Adefovir did not inhibit HDV replication, and the combination had no additional benefit compared with pegylated IFN-\u03b1 monotherapy in terms of the HDV RNA level (Yurdaydin et al. 2006 ).",
            "cite_spans": [
                {
                    "start": 387,
                    "end": 409,
                    "text": "(Yurdaydin et al. 2006",
                    "ref_id": "BIBREF200"
                }
            ],
            "ref_spans": [],
            "section": "Pegylated IFN-\u03b1 Plus Adefovir Dipivoxil"
        },
        {
            "text": "IFN-\u03b1 was one of the first drugs to be tested against human immunodeficiency virus (HIV) in the 1980s. Recombinant human IFN-\u03b1 inhibits HIV replication in normal peripheral blood mononuclear cells (Ho et al. 1985) . However, the ability of IFN\u03b1 to inhibit HIV replication in vitro depends largely on the viral isolate, the target cells, the IFN concentration, and the inoculum. IFN-\u03b1 appears to interfere with the assembly and/or release of newly formed virions (Fernie et al. 1991; Hansen et al. 1992; Poli et al. 1989 ). In addition, IFN-\u03b1 may inhibit viral protein synthesis by blocking viral RNA translation (Coccia et al. 1994) , and may also prevent cell infection (Gendelman et al. 1990 ). In vivo, IFN-\u03b1 has been suggested to block de novo infection rather than virion production, a finding supported by in vitro studies showing that IFN-\u03b1 is more effective when used before rather than after viral challenge ). IFN therapy of HIV infection was abandoned because of its adverse effects, its modest inherent antiviral efficacy, and the development of highly active antiretroviral therapy (HAART) (Lane 1994) .",
            "cite_spans": [
                {
                    "start": 197,
                    "end": 213,
                    "text": "(Ho et al. 1985)",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 462,
                    "end": 482,
                    "text": "(Fernie et al. 1991;",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 483,
                    "end": 502,
                    "text": "Hansen et al. 1992;",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 503,
                    "end": 519,
                    "text": "Poli et al. 1989",
                    "ref_id": "BIBREF158"
                },
                {
                    "start": 612,
                    "end": 632,
                    "text": "(Coccia et al. 1994)",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 671,
                    "end": 693,
                    "text": "(Gendelman et al. 1990",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 1103,
                    "end": 1114,
                    "text": "(Lane 1994)",
                    "ref_id": "BIBREF106"
                }
            ],
            "ref_spans": [],
            "section": "Treatment of HIV Infection with IFN-\u03b1"
        },
        {
            "text": "Several trials have evaluated the antiviral efficacy of standard IFN-\u03b1 in HIVinfected patients also receiving zidovudine, in comparison with zidovudine alone.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Standard IFN-\u03b1"
        },
        {
            "text": "The combination was not more effective than zidovudine monotherapy, either in adults (Fernandez-Cruz et al. 1995; Fischl et al. 1997; Krown et al. 1999) or in infants (Giovannini et al. 1992 ).",
            "cite_spans": [
                {
                    "start": 85,
                    "end": 113,
                    "text": "(Fernandez-Cruz et al. 1995;",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 114,
                    "end": 133,
                    "text": "Fischl et al. 1997;",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 134,
                    "end": 152,
                    "text": "Krown et al. 1999)",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 167,
                    "end": 190,
                    "text": "(Giovannini et al. 1992",
                    "ref_id": "BIBREF66"
                }
            ],
            "ref_spans": [],
            "section": "Standard IFN-\u03b1"
        },
        {
            "text": "In a prospective pilot study involving nine patients coinfected by HIV and HCV genotype 1, HIV replication showed a slow continuous decline during the first week of pegylated IFN-\u03b1 administration, and there was no rebound when pegylated IFN-\u03b1 was withdrawn ). Pegylated IFN-\u03b1 was also reported to display antiretroviral activity in two patients with refractory HIV-related Kaposi's sarcoma (van der Ende et al. 2007 ) and in HIV-infected patients with condylomata acuminata (Brockmeyer et al. 2006) . Finally, pegylated IFN-\u03b1 has been shown to participate in early control of viral replication during primary HIV-1 infection when combined with antiretroviral drugs (Emilie et al. 2001 ). However, there was no control group in this study, and further investigations are therefore needed. Table 4 is illustrating the role of type I IFN in other human viral infections (Hodson et al. 2007; Isomura et al. 1982; Kalil et al. 2005; Lewis and Amsden 2007; Phillpotts et al. 1984; Rahal et al. 2004; Sainz et al. 2004; Scagnolari et al. 2004; Solomon et al. 2003) . Rahal et al. 2004; Solomon et al. 2003 10 Conclusion",
            "cite_spans": [
                {
                    "start": 390,
                    "end": 415,
                    "text": "(van der Ende et al. 2007",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 474,
                    "end": 498,
                    "text": "(Brockmeyer et al. 2006)",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 665,
                    "end": 684,
                    "text": "(Emilie et al. 2001",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 867,
                    "end": 887,
                    "text": "(Hodson et al. 2007;",
                    "ref_id": "BIBREF77"
                },
                {
                    "start": 888,
                    "end": 908,
                    "text": "Isomura et al. 1982;",
                    "ref_id": "BIBREF84"
                },
                {
                    "start": 909,
                    "end": 927,
                    "text": "Kalil et al. 2005;",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 928,
                    "end": 950,
                    "text": "Lewis and Amsden 2007;",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 951,
                    "end": 974,
                    "text": "Phillpotts et al. 1984;",
                    "ref_id": "BIBREF156"
                },
                {
                    "start": 975,
                    "end": 993,
                    "text": "Rahal et al. 2004;",
                    "ref_id": "BIBREF160"
                },
                {
                    "start": 994,
                    "end": 1012,
                    "text": "Sainz et al. 2004;",
                    "ref_id": "BIBREF163"
                },
                {
                    "start": 1013,
                    "end": 1036,
                    "text": "Scagnolari et al. 2004;",
                    "ref_id": "BIBREF170"
                },
                {
                    "start": 1037,
                    "end": 1057,
                    "text": "Solomon et al. 2003)",
                    "ref_id": "BIBREF179"
                },
                {
                    "start": 1060,
                    "end": 1078,
                    "text": "Rahal et al. 2004;",
                    "ref_id": "BIBREF160"
                },
                {
                    "start": 1079,
                    "end": 1098,
                    "text": "Solomon et al. 2003",
                    "ref_id": "BIBREF179"
                }
            ],
            "ref_spans": [
                {
                    "start": 788,
                    "end": 795,
                    "text": "Table 4",
                    "ref_id": "TABREF6"
                }
            ],
            "section": "Pegylated IFN-\u03b1"
        },
        {
            "text": "In conclusion, IFNs have proven to be invaluable tools in the fight against chronic viral hepatitis. In these indications, their antiviral properties play a major role and it remains unclear whether their immunomodulatory properties are also important. Disappointing results obtained with purely immunomodulatory molecules, such as interleukins or Toll-like receptor agonists suggest that, if immunomodulation plays any role, potent inhibition of viral replication is also needed. The role of IFNs in the treatment of viral infections other than hepatitis B and C remains elusive.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Treatment of Other Viral Infections with Type I IFN in Humans"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C",
            "authors": [],
            "year": null,
            "venue": "Hepatology",
            "volume": "26",
            "issn": "",
            "pages": "2--10",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "EASL International Consensus Conference on hepatitis C. Paris",
            "authors": [],
            "year": 1999,
            "venue": "",
            "volume": "31",
            "issn": "",
            "pages": "3--8",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "National Institutes of Health Consensus Development Conference statement: management of hepatitis C",
            "authors": [],
            "year": 2002,
            "venue": "Hepatology",
            "volume": "36",
            "issn": "",
            "pages": "3--20",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Valopicitabine (NM283), alone or with peg-interferon, compared to peginterferon/ribavirin (PEGIFN/RBV) retreatment in hepatitis C patients with prior non-response to PEGIFN/RBV: week 24 results",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "H"
                    ],
                    "last": "Afdhal",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "O&apos;brien",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Godofsky",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rodriguez-Torres",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Pappas",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Pockros",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lawitz",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Bzowej",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Rustgi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sulkowski",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "E"
                    ],
                    "last": "Sherman",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Jacobson",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Chao",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Knox",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Pietropaolo",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Hepatol",
            "volume": "44",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B",
            "authors": [
                {
                    "first": "U",
                    "middle": [
                        "S"
                    ],
                    "last": "Akarca",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ersoz",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gunsar",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Karasu",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Saritas",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Yuce",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Batur",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Antivir Ther",
            "volume": "9",
            "issn": "",
            "pages": "325--334",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Ank",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "West",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bartholdy",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Eriksson",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "R"
                    ],
                    "last": "Thomsen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Paludan",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Virol",
            "volume": "80",
            "issn": "",
            "pages": "4501--4509",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "G"
                    ],
                    "last": "Bain",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "D"
                    ],
                    "last": "Kaita",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Yoshida",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Swain",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "J"
                    ],
                    "last": "Heathcote",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "U"
                    ],
                    "last": "Neumann",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fiscella",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Osborn",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "W"
                    ],
                    "last": "Cronin",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "W"
                    ],
                    "last": "Freimuth",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Subramanian",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Hepatol",
            "volume": "44",
            "issn": "",
            "pages": "671--678",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Comparable antiviral response rates with albumin interferon alpha-2b dosed at Q2W or Q4W intervals in naive subjects with genotype 2 or 3 chronic hepatitis C",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "G"
                    ],
                    "last": "Bain",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marotta",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kaita",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Yoshida",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Swain",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bailey",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "U"
                    ],
                    "last": "Neumann",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "W"
                    ],
                    "last": "Cronin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Pulkstenis",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Subramanian",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Hepatol",
            "volume": "46",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "A Phase I/II study evaluating escalating doses of recombinant human albumininterferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Balan",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "R"
                    ],
                    "last": "Nelson",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Sulkowski",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "T"
                    ],
                    "last": "Everson",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "R"
                    ],
                    "last": "Lambiase",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "H"
                    ],
                    "last": "Wiesner",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Dickson",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "Post",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "R"
                    ],
                    "last": "Redfield",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "L"
                    ],
                    "last": "Davis",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "U"
                    ],
                    "last": "Neumann",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Osborn",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "W"
                    ],
                    "last": "Freimuth",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Subramanian",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Antivir Ther",
            "volume": "11",
            "issn": "",
            "pages": "35--45",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Barbaro",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Lorenzo",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Soldini",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Giancaspro",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Pellicelli",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Grisorio",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Barbarini",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Scand J Gastroenterol",
            "volume": "34",
            "issn": "",
            "pages": "928--933",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Barbaro",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zechini",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Pellicelli",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Francavilla",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Scotto",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Bacca",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bruno",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Babudieri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Annese",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Matarazzo",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Stefano",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Barbarini",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Hepatol",
            "volume": "35",
            "issn": "",
            "pages": "406--411",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Blatt",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Davis",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "B"
                    ],
                    "last": "Klein",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Taylor",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "J Interferon Cytokine Res",
            "volume": "16",
            "issn": "",
            "pages": "489--499",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "O"
                    ],
                    "last": "Bocher",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Schuchmann",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Link",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Hillenbrand",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Rahman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sprinzl",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mudter",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "F"
                    ],
                    "last": "Lohr",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "R"
                    ],
                    "last": "Galle",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Liver Int",
            "volume": "26",
            "issn": "",
            "pages": "319--325",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Cellular responses to interferon-gamma",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Boehm",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Klamp",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Groot",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Howard",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Annu Rev Immunol",
            "volume": "15",
            "issn": "",
            "pages": "749--795",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Long term effect of alpha interferon in children with chronic hepatitis B",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Bortolotti",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Jara",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Barbera",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "V"
                    ],
                    "last": "Gregorio",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Vegnente",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zancan",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Hierro",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Crivellaro",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Vergani",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Iorio",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Pace",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Con",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gatta",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Gut",
            "volume": "46",
            "issn": "",
            "pages": "715--718",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Brillanti",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Garson",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Foli",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Whitby",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Deaville",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Masci",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Miglioli",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Barbara",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Gastroenterology",
            "volume": "107",
            "issn": "",
            "pages": "812--817",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Treatment of condylomata acuminata with pegylated interferon alfa-2b in HIV-infected patients",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "H"
                    ],
                    "last": "Brockmeyer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Poffhoff",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bader",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hochdorfer",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Schlottmann",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Rasokat",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Altmeyer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kreuter",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Eur J Med Res",
            "volume": "11",
            "issn": "",
            "pages": "27--32",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2a plus ribavirin combination",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Bronowicki",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Ouzan",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Asselah",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Desmorat",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Zarski",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Foucher",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bourl\u00e8re",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Renou",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Tran",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Melin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "H\u00e9zode",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Chevallier",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bouvier-Alias",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chevaliez",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Montestruc",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Lonjon-Domanec",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Pawlotsky",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Gastroenterology",
            "volume": "131",
            "issn": "",
            "pages": "1339--1341",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Antiviral activity of CHO-SS cellderived human omega interferon and other human interferons against HCV RNA replicons and related viruses",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "E"
                    ],
                    "last": "Buckwold",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nalca",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wells",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Russell",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Collins",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ptak",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Scribner",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Blanchett",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Alessi",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Langecker",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Antiviral Res",
            "volume": "73",
            "issn": "",
            "pages": "118--125",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "A short course of pegylated interferon-alpha in acute HCV hepatitis",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Calleri",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Cariti",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gaiottino",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Rosa",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "G"
                    ],
                    "last": "Bargiacchi",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Audagnotto",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Quaglia",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Blasi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Romano",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Traverso",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Leo",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Carbone",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Del",
                    "middle": [],
                    "last": "Mastro",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Tinelli",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Caramello",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Perri",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Viral Hepat",
            "volume": "14",
            "issn": "",
            "pages": "116--121",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Canbakan",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Senturk",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Tabak",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Akdogan",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Tahan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mert",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Sut",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ozaras",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Midilli",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ozbay",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Gastroenterol Hepatol",
            "volume": "21",
            "issn": "",
            "pages": "657--663",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "F"
                    ],
                    "last": "Carman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Jacyna",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hadziyannis",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Karayiannis",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Mcgarvey",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Makris",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "C"
                    ],
                    "last": "Thomas",
                    "suffix": ""
                }
            ],
            "year": 1989,
            "venue": "Lancet",
            "volume": "2",
            "issn": "",
            "pages": "588--591",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Carreno",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hadziyannis",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Salmeron",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Diago",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "E"
                    ],
                    "last": "Kitis",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Vafiadis",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Schalm",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zahm",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Manzarbeitia",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "J"
                    ],
                    "last": "Jimenez",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Quiroga",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Hepatology",
            "volume": "30",
            "issn": "",
            "pages": "277--282",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Castelnau",
                    "suffix": ""
                },
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Gal",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ripault",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Gordien",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Martinot-Peignoux",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Boyer",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Pham",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "N"
                    ],
                    "last": "Maylin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bedossa",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Deny",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gault",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "44",
            "issn": "",
            "pages": "728--735",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Multicenter randomized, controlled study of intramuscular administration of interferon-beta for the treatment of chronic hepatitis C",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Castro",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Suarez",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Inglada",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Carballo",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Dominguez",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Diago",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Such",
                    "suffix": ""
                },
                {
                    "first": "Del",
                    "middle": [],
                    "last": "Olmo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Perez-Mota",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pedreira",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Quiroga",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Carreno",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Interferon Cytokine Res",
            "volume": "17",
            "issn": "",
            "pages": "27--30",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "Y"
                    ],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "W"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Chim",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Sung",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Hepatology",
            "volume": "41",
            "issn": "",
            "pages": "1357--1364",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "W"
                    ],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "Y"
                    ],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "W"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "T"
                    ],
                    "last": "Liew",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Chim",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "K"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "C"
                    ],
                    "last": "Hung",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "T"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Tam",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "W"
                    ],
                    "last": "Lam",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Sung",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Ann Intern Med",
            "volume": "142",
            "issn": "",
            "pages": "240--250",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Evolution of a cytokine using DNA family shuffling",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "C"
                    ],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "T"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "W"
                    ],
                    "last": "Cox",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "N"
                    ],
                    "last": "Dawes",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "P"
                    ],
                    "last": "Stemmer",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Punnonen",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Patten",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Nat Biotechnol",
            "volume": "17",
            "issn": "",
            "pages": "793--797",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Diversity and relatedness among the type I interferons",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Baig",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "N"
                    ],
                    "last": "Fish",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Interferon Cytokine Res",
            "volume": "24",
            "issn": "",
            "pages": "687--698",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Interferons and apoptosis",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Clemens",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Interferon Cytokine Res",
            "volume": "23",
            "issn": "",
            "pages": "277--292",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Specific inhibition of viral protein synthesis in HIVinfected cells in response to interferon treatment",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Coccia",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Krust",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "G"
                    ],
                    "last": "Hovanessian",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "J Biol Chem",
            "volume": "269",
            "issn": "",
            "pages": "23087--23094",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "G"
                    ],
                    "last": "Cooksley",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Piratvisuth",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "D"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Mahachai",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Chao",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tanwandee",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Chutaputti",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "Y"
                    ],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "E"
                    ],
                    "last": "Zahm",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Pluck",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Viral Hepat",
            "volume": "10",
            "issn": "",
            "pages": "298--305",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "TLRs, NLRs and RLRs: a trinity of pathogen sensors that cooperate in innate immunity",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Creagh",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "O&apos;neill",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Trends Immunol",
            "volume": "27",
            "issn": "",
            "pages": "352--357",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Dash",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Prabhu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hazari",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Bastian",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Garry",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zou",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Haque",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Joshi",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "G"
                    ],
                    "last": "Regenstein",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "N"
                    ],
                    "last": "Thung",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Liver Int",
            "volume": "25",
            "issn": "",
            "pages": "580--594",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Consensus statement (long version)",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "De Franchis",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hadengue",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lavanchy",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lok",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Mcintyre",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mele",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Paumgartner",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pietrangelo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Rodes",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Rosenberg",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Valla",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "EASL International Consensus Conference on Hepatitis B. 13-14",
            "volume": "39",
            "issn": "",
            "pages": "3--25",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "The early HCV RNA dynamics in patients with acute hepatitis C treated with pegylated interferon-alpha2b",
            "authors": [
                {
                    "first": "De",
                    "middle": [],
                    "last": "Rosa",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "G"
                    ],
                    "last": "Bargiacchi",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Audagnotto",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Garazzino",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Cariti",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Veronese",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Raiteri",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Calleri",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Perri",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Antivir Ther",
            "volume": "11",
            "issn": "",
            "pages": "165--171",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Hepatitis D virus",
            "authors": [
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Bisceglie",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Optimal therapy of hepatitis C",
            "authors": [
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Bisceglie",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Hoofnagle",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Hepatology",
            "volume": "36",
            "issn": "",
            "pages": "121--127",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Pilot study of recombinant human alpha-interferon for chronic type B hepatitis",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Dooley",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "L"
                    ],
                    "last": "Davis",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Peters",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Waggoner",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Goodman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Hoofnagle",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "Gastroenterology",
            "volume": "90",
            "issn": "",
            "pages": "150--157",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Doyle",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Schreckhise",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Khuu-Duong",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Henderson",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Rosler",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Storey",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Barahmand-Pour",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sivakumar",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Birks",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Foster",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "Clegg",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Wietzke-Braun",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mihm",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Klucher",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "44",
            "issn": "",
            "pages": "896--906",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Dumoutier",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lejeune",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hor",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Fickenscher",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Renauld",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Biochem J",
            "volume": "370",
            "issn": "",
            "pages": "391--396",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Dumoutier",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Tounsi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Michiels",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Sommereyns",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "V"
                    ],
                    "last": "Kotenko",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Renauld",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Biol Chem",
            "volume": "279",
            "issn": "",
            "pages": "32269--32274",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Three-dimensional structure of recombinant human interferon-gamma",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Ealick",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Cook",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Vijay-Kumar",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Carson",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "L"
                    ],
                    "last": "Nagabhushan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "P"
                    ],
                    "last": "Trotta",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "E"
                    ],
                    "last": "Bugg",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Science",
            "volume": "252",
            "issn": "",
            "pages": "698--702",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) Study",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Emilie",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Burgard",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Lascoux-Combe",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Laughlin",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Krzysiek",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Pignon",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Rudent",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Molina",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Livrozet",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Souala",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Chene",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Grangeot-Keros",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Galanaud",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sereni",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rouzioux",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "AIDS",
            "volume": "15",
            "issn": "",
            "pages": "1435--1437",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Lamivudine and IFN-beta sequential therapy in HBe antigen-positive patients with chronic hepatitis B virus genotype C infection",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Enomoto",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Tamori",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "T"
                    ],
                    "last": "Kohmoto",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hayashi",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Jomura",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Habu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Sakaguchi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Takeda",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kawada",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Seki",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shiomi",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Koh",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nishiguchi",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Interferon Cytokine Res",
            "volume": "27",
            "issn": "",
            "pages": "201--207",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Treatment of chronic hepatitis delta with pegylated interferon-alpha2b",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Erhardt",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Gerlich",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Starke",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Wend",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Donner",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sagir",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Heintges",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Haussinger",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Liver Int",
            "volume": "26",
            "issn": "",
            "pages": "805--810",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Treatment of chronic hepatitis D with interferon alfa-2a",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Farci",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mandas",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Coiana",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Desmet",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Van Eyken",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Gibo",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Caruso",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Scaccabarozzi",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Criscuolo",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "N Engl J Med",
            "volume": "330",
            "issn": "",
            "pages": "88--94",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Farci",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Roskams",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Chessa",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Peddis",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "P"
                    ],
                    "last": "Mazzoleni",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Scioscia",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Serra",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Loy",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Caruso",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Desmet",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "H"
                    ],
                    "last": "Purcell",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Balestrieri",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Gastroenterology",
            "volume": "126",
            "issn": "",
            "pages": "1740--1749",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Fattovich",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Giustina",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sanchez-Tapias",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Quero",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mas",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "G"
                    ],
                    "last": "Olivotto",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Solinas",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Almasio",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hadziyannis",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Degos",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "De Moura",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Krogsgaard",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Pantalena",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Realdi",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Corrocher",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Schalm",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Am J Gastroenterol",
            "volume": "93",
            "issn": "",
            "pages": "896--900",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Fattovich",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Giustina",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Christensen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Pantalena",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Zagni",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Realdi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Schalm",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Gut",
            "volume": "46",
            "issn": "",
            "pages": "420--426",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 \u00d7 10(6)/L: results of the Zidon trial",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Fernandez-Cruz",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Lang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Frissen",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Furner",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Chateauvert",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Boucher",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Dowd",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Stevens",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "AIDS",
            "volume": "9",
            "issn": "",
            "pages": "1025--1035",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "F"
                    ],
                    "last": "Fernie",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Poli",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Fauci",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "J Virol",
            "volume": "65",
            "issn": "",
            "pages": "3968--3971",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Fischl",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "D"
                    ],
                    "last": "Richman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Saag",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "C"
                    ],
                    "last": "Meng",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "E"
                    ],
                    "last": "Squires",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Holden-Wiltse",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Meehan",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Acquir Immune Defic Syndr Hum Retrovirol",
            "volume": "16",
            "issn": "",
            "pages": "247--253",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Flink",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "E"
                    ],
                    "last": "Hansen",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "J"
                    ],
                    "last": "Heathcote",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "V"
                    ],
                    "last": "Feinman",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Simsek",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Karayalcin",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Mach",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "F"
                    ],
                    "last": "Leemans",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "De Man",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Verhey",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Schalm",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Janssen",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Am J Gastroenterol",
            "volume": "101",
            "issn": "",
            "pages": "2523--2529",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Flink",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Van Zonneveld",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "E"
                    ],
                    "last": "Hansen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "De Man",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Schalm",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Janssen",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Am J Gastroenterol",
            "volume": "101",
            "issn": "",
            "pages": "297--303",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Frese",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Schwarzle",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Barth",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Krieger",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Lohmann",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mihm",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Haller",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bartenschlager",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Hepatology",
            "volume": "35",
            "issn": "",
            "pages": "694--703",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Improved sustained virological response (SVR) rates with higher, fixed doses of peginterferon alfa-2a (40 kD) (Pegasys) plus ribavirin (RBV) (Copegus) in patients with \"difficult-to-treat",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fried",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Jensen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rodriguez-Torres",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Nyberg",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Bisceglie",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Morgan",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Pockros",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cupelli",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Nelson",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "characteristics. Hepatology",
            "volume": "44",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Fried",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Shiffman",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Reddy",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Marinos",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "L"
                    ],
                    "last": "Goncales",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Haussinger",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Diago",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Carosi",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Dhumeaux",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Craxi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hoffman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "N Engl J Med",
            "volume": "347",
            "issn": "",
            "pages": "975--982",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "U"
                    ],
                    "last": "Gack",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Shin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "Joo",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Urano",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Takeuchi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Akira",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Inoue",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "U"
                    ],
                    "last": "Jung",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Nature",
            "volume": "446",
            "issn": "",
            "pages": "916--920",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Chronic hepatitis D: a vanishing disease? An Italian multicenter study",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "B"
                    ],
                    "last": "Gaeta",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Stroffolini",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Chiaramonte",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ascione",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Stornaiuolo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lobello",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Sagnelli",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Brunetto",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rizzetto",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Hepatology",
            "volume": "32",
            "issn": "",
            "pages": "824--827",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Evasion of intracellular host defence by hepatitis C virus",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gale",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Foy",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nature",
            "volume": "436",
            "issn": "",
            "pages": "939--945",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Ribavirin treatment for chronic hepatitis D: a pilot study",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Garripoli",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Marco",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Cozzolongo",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Costa",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Smedile",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Fabiano",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bonino",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Rizzetto",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Verme",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Craxi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Liver",
            "volume": "14",
            "issn": "",
            "pages": "154--157",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts)",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gattoni",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Parlato",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Vangieri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bresciani",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Derna",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Clin Ter",
            "volume": "157",
            "issn": "",
            "pages": "377--386",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Interferon-gamma: biologic functions and HCV therapy (type I/II) (2 of 2 parts)",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gattoni",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Parlato",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Vangieri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bresciani",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Derna",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Clin Ter",
            "volume": "157",
            "issn": "",
            "pages": "457--468",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Gaudin",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Faure",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Godinot",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gerard",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Trepo",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Liver",
            "volume": "15",
            "issn": "",
            "pages": "45--52",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "E"
                    ],
                    "last": "Gendelman",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Baca",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Turpin",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "C"
                    ],
                    "last": "Kalter",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hansen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Orenstein",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "W"
                    ],
                    "last": "Dieffenbach",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Friedman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Meltzer",
                    "suffix": ""
                }
            ],
            "year": 1990,
            "venue": "J Immunol",
            "volume": "145",
            "issn": "",
            "pages": "2669--26676",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Combined zidovudine and interferon-alpha 2a therapy in children with acquired immune deficiency syndrome",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Giovannini",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "V"
                    ],
                    "last": "Zuccotti",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Biasucci",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Locatelli",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Riva",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Int Med Res",
            "volume": "20",
            "issn": "",
            "pages": "295--301",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "HCV RNA results from a Phase II, randomized, open-labeled study of omega interferon (IFN) with or without ribavirin in IFN-naive genotype 1 chronic HCV patients",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "V"
                    ],
                    "last": "Gorbakov",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Oronsky",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lang",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Hepatology",
            "volume": "42",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Gough",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sabapathy",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "Y"
                    ],
                    "last": "Ko",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "A"
                    ],
                    "last": "Arthur",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "D"
                    ],
                    "last": "Schreiber",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Trapani",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Clarke",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "W"
                    ],
                    "last": "Johnstone",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Biol Chem",
            "volume": "282",
            "issn": "",
            "pages": "938--946",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Noncytolytic control of viral infections by the innate and adaptive immune response",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "G"
                    ],
                    "last": "Guidotti",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "V"
                    ],
                    "last": "Chisari",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Annu Rev Immunol",
            "volume": "19",
            "issn": "",
            "pages": "65--91",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Two-year interferon therapy with or without ribavirin in chronic delta hepatitis",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gunsar",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [
                        "S"
                    ],
                    "last": "Akarca",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ersoz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Kobak",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Karasu",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Yuce",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ilter",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Batur",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Antivir Ther",
            "volume": "10",
            "issn": "",
            "pages": "721--726",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "A pilot study of recombinant interferon beta-1a for the treatment of chronic hepatitis C",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Habersetzer",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Boyer",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Bailly",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "N"
                    ],
                    "last": "Ahmed",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Alam",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Benhamou",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Trepo",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Liver",
            "volume": "20",
            "issn": "",
            "pages": "437--441",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Hadziyannis",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Sette",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "R"
                    ],
                    "last": "Morgan",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Balan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Diago",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ramadori",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Bodenheimer",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Bernstein",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rizzetto",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zeuzem",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Pockros",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Ackrill",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Ann Intern Med",
            "volume": "140",
            "issn": "",
            "pages": "346--355",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "D"
                    ],
                    "last": "Hansen",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Nara",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "K"
                    ],
                    "last": "Maheshwari",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "S"
                    ],
                    "last": "Sidhu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Bernbaum",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Hoekzema",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Meltzer",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "E"
                    ],
                    "last": "Gendelman",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Virol",
            "volume": "66",
            "issn": "",
            "pages": "7543--7548",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "NF-kappaB and the immune response",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Hayden",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "P"
                    ],
                    "last": "West",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ghosh",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Oncogene",
            "volume": "25",
            "issn": "",
            "pages": "6758--6780",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "Efficacy and safety of peginterferon alpha-2a administrated every five days in combination with ribavirin in HCV genotype 1-infected patients with severe fibrosis not responding to weekly administrations of peginterferon in combination with ribavirin",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hezode",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bouvier-Alias",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Roudot-Thoraval",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zafrani",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Dhumeaux",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mallat",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Pawlotsky",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "44",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "D"
                    ],
                    "last": "Ho",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Hartshorn",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "R"
                    ],
                    "last": "Rota",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Andrews",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Kaplan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "T"
                    ],
                    "last": "Schooley",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Hirsch",
                    "suffix": ""
                }
            ],
            "year": 1985,
            "venue": "Lancet",
            "volume": "1",
            "issn": "",
            "pages": "602--604",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Hodson",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "F"
                    ],
                    "last": "Strippoli",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Webster",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Craig",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Cochrane Database Syst Rev",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "IRF-7 is the master regulator of type-I interferon-dependent immune responses",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Honda",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yanai",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Negishi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Asagiri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sato",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Mizutani",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Shimada",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ohba",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Takaoka",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Yoshida",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Taniguchi",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nature",
            "volume": "434",
            "issn": "",
            "pages": "772--777",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Hong",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Shin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "V"
                    ],
                    "last": "Kotenko",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Virus Res",
            "volume": "126",
            "issn": "",
            "pages": "245--249",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Hoofnagle",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "D"
                    ],
                    "last": "Mullen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "B"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Rustgi",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Bisceglie",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Peters",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Waggoner",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "N Engl J Med",
            "volume": "315",
            "issn": "",
            "pages": "1575--1578",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "Combination therapy with interferon-alpha and ribavirin as immunomodulators in patients with chronic hepatitis C",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Horiike",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Onji",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Gastroenterol",
            "volume": "38",
            "issn": "",
            "pages": "302--304",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "K"
                    ],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "S"
                    ],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Lam",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "Y"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "T"
                    ],
                    "last": "Fung",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "M"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Lo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "K"
                    ],
                    "last": "Lau",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Aliment Pharmacol Ther",
            "volume": "23",
            "issn": "",
            "pages": "1171--1178",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "Virus interference. I. The interferon",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Isaacs",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lindenmann",
                    "suffix": ""
                }
            ],
            "year": 1957,
            "venue": "Proc R Soc Lond B Biol Sci",
            "volume": "147",
            "issn": "",
            "pages": "258--267",
            "other_ids": {}
        },
        "BIBREF84": {
            "ref_id": "b84",
            "title": "The preventive effect of human interferon-alpha on influenza infection; modification of clinical manifestations of influenza in children in a closed community",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Isomura",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ichikawa",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Miyazu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Naruse",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Shibata",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Imanishi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Matsuo",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kishida",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Karaki",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Biken J",
            "volume": "25",
            "issn": "",
            "pages": "131--137",
            "other_ids": {}
        },
        "BIBREF85": {
            "ref_id": "b85",
            "title": "Weight-based ribavirin dosing (WBD) increases sustained viral response (SVR) in patients with chronic hepatitis C (CHC): final results of the WIN-R study, a US community-based trial",
            "authors": [
                {
                    "first": "I",
                    "middle": [
                        "M"
                    ],
                    "last": "Jacobson",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Brown",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Freilich",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Afdhal",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kwo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Santoro",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Becker",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Wakil",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Pound",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Godofsky",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Staruss",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Bernstein",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Flamm",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Bala",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Araya",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Davis",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Monsour",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Vierling",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Regenstein",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Balan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dragutsky",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Epstein",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "W"
                    ],
                    "last": "Herring",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Rubin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Galler",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Pauly",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "H"
                    ],
                    "last": "Griffel",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Brass",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Hepatology",
            "volume": "42",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "Treatment of acute hepatitis C with interferon alfa-2b",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Jaeckel",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cornberg",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wedemeyer",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Santantonio",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mayer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zankel",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Pastore",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dietrich",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Trautwein",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Manns",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "N Engl J Med",
            "volume": "345",
            "issn": "",
            "pages": "1452--1457",
            "other_ids": {}
        },
        "BIBREF87": {
            "ref_id": "b87",
            "title": "Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "K"
                    ],
                    "last": "Jang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Chung",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Choi",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Ryu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Shin",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "S"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "H"
                    ],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "C"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "S"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Suh",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Gastroenterol Hepatol",
            "volume": "19",
            "issn": "",
            "pages": "1363--1368",
            "other_ids": {}
        },
        "BIBREF88": {
            "ref_id": "b88",
            "title": "Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Janssen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Van Zonneveld",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Senturk",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zeuzem",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [
                        "S"
                    ],
                    "last": "Akarca",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cakaloglu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Simon",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "So",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Gerken",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "De Man",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "G"
                    ],
                    "last": "Niesters",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zondervan",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hansen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Schalm",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Lancet",
            "volume": "365",
            "issn": "",
            "pages": "123--129",
            "other_ids": {}
        },
        "BIBREF89": {
            "ref_id": "b89",
            "title": "Ribavirin dosing in chronic hepatitis C: application of population pharmacokinetic-pharmacodynamic models",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Jen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Laughlin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chung",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Heft",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B"
                    ],
                    "last": "Affrime",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Gupta",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Glue",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Hajian",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Clin Pharmacol Ther",
            "volume": "72",
            "issn": "",
            "pages": "349--361",
            "other_ids": {}
        },
        "BIBREF90": {
            "ref_id": "b90",
            "title": "Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Jen",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Glue",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gupta",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zambas",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Hajian",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Ther Drug Monit",
            "volume": "22",
            "issn": "",
            "pages": "555--565",
            "other_ids": {}
        },
        "BIBREF91": {
            "ref_id": "b91",
            "title": "Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Jensen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "R"
                    ],
                    "last": "Morgan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Pockros",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Reddy",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Hadziyannis",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Ferenci",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Ackrill",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Willems",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "43",
            "issn": "",
            "pages": "954--960",
            "other_ids": {}
        },
        "BIBREF92": {
            "ref_id": "b92",
            "title": "A pilot study of long-term weekly interferon-beta administration for chronic hepatitis B",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kagawa",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Morizane",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Saito",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tsunematsu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tada",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kumagai",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Tsuchimoto",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Sugiura",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mukai",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tsuchiya",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Am J Gastroenterol",
            "volume": "88",
            "issn": "",
            "pages": "212--216",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Kalil",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Devetten",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Singh",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Lesiak",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "P"
                    ],
                    "last": "Poage",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Bargenquast",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Fayad",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "G"
                    ],
                    "last": "Freifeld",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Clin Infect Dis",
            "volume": "40",
            "issn": "",
            "pages": "764--766",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "Cell type-specific involvement of RIG-I in antiviral response",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kato",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sato",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yoneyama",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yamamoto",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Uematsu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Matsui",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tsujimura",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Takeda",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Fujita",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Takeuchi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Akira",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Immunity",
            "volume": "23",
            "issn": "",
            "pages": "19--28",
            "other_ids": {}
        },
        "BIBREF95": {
            "ref_id": "b95",
            "title": "Alpha interferon and ribavirin combination therapy of chronic hepatitis D",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kaymakoglu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Karaca",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Demir",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Poturoglu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Danalioglu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Badur",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bozaci",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Besisik",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cakaloglu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Okten",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Antimicrob Agents Chemother",
            "volume": "49",
            "issn": "",
            "pages": "1135--1138",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kaymakoglu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Danalioglu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Demir",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Karaca",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Akyuz",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Onel",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Badur",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Cevikbas",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Besisik",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cakaloglu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Okten",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Dig Dis Sci",
            "volume": "52",
            "issn": "",
            "pages": "727--731",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "Pegylated interferon alfa-2b monotherapy and pegylated interferon alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kaymakoglu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Oguz",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Gur",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gurel",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Tankurt",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ersoz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ozenirler",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Kalayci",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Poturoglu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cakaloglu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Okten",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Antimicrob Agents Chemother",
            "volume": "51",
            "issn": "",
            "pages": "3020--3022",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "Therapy of hepatitis C: consensus interferon trials",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "B"
                    ],
                    "last": "Keeffe",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "B"
                    ],
                    "last": "Hollinger",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Hepatology",
            "volume": "26",
            "issn": "",
            "pages": "101--107",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "B"
                    ],
                    "last": "Keeffe",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "T"
                    ],
                    "last": "Dieterich",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Han",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "M"
                    ],
                    "last": "Jacobson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "R"
                    ],
                    "last": "Schiff",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Tobias",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "L"
                    ],
                    "last": "Wright",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Clin Gastroenterol Hepatol",
            "volume": "4",
            "issn": "",
            "pages": "936--962",
            "other_ids": {}
        },
        "BIBREF100": {
            "ref_id": "b100",
            "title": "Interferon-beta induction/interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "I"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Sasase",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Taniguchi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Mita",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kinoshita",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Togitani",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Shikata",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kimura",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Izawa",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ohtani",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Nakao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Muramoto",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nabeshima",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ishii",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Tanaka",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hayashi",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Int J Clin Pharmacol Res",
            "volume": "25",
            "issn": "",
            "pages": "71--76",
            "other_ids": {}
        },
        "BIBREF101": {
            "ref_id": "b101",
            "title": "Development of pegylated interferons for the treatment of chronic hepatitis C",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kozlowski",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Charles",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Harris",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "BioDrugs",
            "volume": "15",
            "issn": "",
            "pages": "419--429",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Krown",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Aeppli",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "H"
                    ],
                    "last": "Balfour",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Acquir Immune Defic Syndr Hum Retrovirol",
            "volume": "20",
            "issn": "",
            "pages": "245--254",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "Interferon-kappa, a novel type I interferon expressed in human keratinocytes",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Lafleur",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Nardelli",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tsareva",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Mather",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Semenuk",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Buergin",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chinchilla",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Roshke",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Ruben",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Pitha",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "A"
                    ],
                    "last": "Coleman",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Moore",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Biol Chem",
            "volume": "276",
            "issn": "",
            "pages": "39765--39771",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Lampertico",
                    "suffix": ""
                },
                {
                    "first": "Del",
                    "middle": [],
                    "last": "Ninno",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Manzin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Donato",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Rumi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Lunghi",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Morabito",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Clementi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Colombo",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Hepatology",
            "volume": "26",
            "issn": "",
            "pages": "1621--1625",
            "other_ids": {}
        },
        "BIBREF105": {
            "ref_id": "b105",
            "title": "Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Lampertico",
                    "suffix": ""
                },
                {
                    "first": "Del",
                    "middle": [],
                    "last": "Ninno",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Vigano",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Romeo",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Donato",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Sablon",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Morabito",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Colombo",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Hepatology",
            "volume": "37",
            "issn": "",
            "pages": "756--763",
            "other_ids": {}
        },
        "BIBREF106": {
            "ref_id": "b106",
            "title": "Interferons in HIV and related diseases",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "C"
                    ],
                    "last": "Lane",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "AIDS",
            "volume": "8",
            "issn": "",
            "pages": "19--23",
            "other_ids": {}
        },
        "BIBREF107": {
            "ref_id": "b107",
            "title": "Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "E"
                    ],
                    "last": "Lanford",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Guerra",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "R"
                    ],
                    "last": "Averett",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Pfeiffer",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chavez",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Notvall",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bigger",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Virol",
            "volume": "77",
            "issn": "",
            "pages": "1092--1104",
            "other_ids": {}
        },
        "BIBREF108": {
            "ref_id": "b108",
            "title": "Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "T"
                    ],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Everhart",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "E"
                    ],
                    "last": "Kleiner",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Vergalla",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Schmid",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Hoofnagle",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Gastroenterology",
            "volume": "113",
            "issn": "",
            "pages": "1660--1667",
            "other_ids": {}
        },
        "BIBREF109": {
            "ref_id": "b109",
            "title": "10-Year follow-up after interferon-alpha therapy for chronic hepatitis C",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "T"
                    ],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "E"
                    ],
                    "last": "Kleiner",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Ghany",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Schmid",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Hoofnagle",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Hepatology",
            "volume": "28",
            "issn": "",
            "pages": "1121--1127",
            "other_ids": {}
        },
        "BIBREF110": {
            "ref_id": "b110",
            "title": "Lamivudine for chronic delta hepatitis",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "T"
                    ],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Doo",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "E"
                    ],
                    "last": "Kleiner",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Schmid",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Kuhns",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Hoofnagle",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Hepatology",
            "volume": "30",
            "issn": "",
            "pages": "546--549",
            "other_ids": {}
        },
        "BIBREF111": {
            "ref_id": "b111",
            "title": "Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "T"
                    ],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "E"
                    ],
                    "last": "Kleiner",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Bisceglie",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Hoofnagle",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Gastroenterology",
            "volume": "117",
            "issn": "",
            "pages": "1229--1233",
            "other_ids": {}
        },
        "BIBREF112": {
            "ref_id": "b112",
            "title": "Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "K"
                    ],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Piratvisuth",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "X"
                    ],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Thongsawat",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Cooksley",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Gane",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Fried",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "C"
                    ],
                    "last": "Chow",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Paik",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "Y"
                    ],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Berg",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Flisiak",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Mccloud",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Pluck",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "N Engl J Med",
            "volume": "352",
            "issn": "",
            "pages": "2682--2695",
            "other_ids": {}
        },
        "BIBREF113": {
            "ref_id": "b113",
            "title": "The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "F"
                    ],
                    "last": "Leemans",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Flink",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Janssen",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "G"
                    ],
                    "last": "Niesters",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Schalm",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "De Man",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Hepatol",
            "volume": "44",
            "issn": "",
            "pages": "507--511",
            "other_ids": {}
        },
        "BIBREF114": {
            "ref_id": "b114",
            "title": "Successful treatment of West Nile virus infection after approximately 3 weeks into the disease course",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lewis",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Amsden",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Pharmacotherapy",
            "volume": "27",
            "issn": "",
            "pages": "455--458",
            "other_ids": {}
        },
        "BIBREF115": {
            "ref_id": "b115",
            "title": "Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "F"
                    ],
                    "last": "Liaw",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "K"
                    ],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Merican",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Mccaughan",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Gane",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Kao",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Omata",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Liver Int",
            "volume": "25",
            "issn": "",
            "pages": "472--489",
            "other_ids": {}
        },
        "BIBREF116": {
            "ref_id": "b116",
            "title": "Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "N"
                    ],
                    "last": "Chien",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "S"
                    ],
                    "last": "Sheen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "F"
                    ],
                    "last": "Liaw",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Hepatol",
            "volume": "46",
            "issn": "",
            "pages": "45--52",
            "other_ids": {}
        },
        "BIBREF117": {
            "ref_id": "b117",
            "title": "High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Lindahl",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Stahle",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bruchfeld",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Schvarcz",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Hepatology",
            "volume": "41",
            "issn": "",
            "pages": "275--279",
            "other_ids": {}
        },
        "BIBREF118": {
            "ref_id": "b118",
            "title": "A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Lindsay",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Trepo",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Heintges",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Shiffman",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Hoefs",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "R"
                    ],
                    "last": "Schiff",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "D"
                    ],
                    "last": "Goodman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Laughlin",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Albrecht",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Hepatology",
            "volume": "34",
            "issn": "",
            "pages": "395--403",
            "other_ids": {}
        },
        "BIBREF119": {
            "ref_id": "b119",
            "title": "Chronic hepatitis B",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Lok",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "J"
                    ],
                    "last": "Mcmahon",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Hepatology",
            "volume": "45",
            "issn": "",
            "pages": "507--539",
            "other_ids": {}
        },
        "BIBREF120": {
            "ref_id": "b120",
            "title": "Long-term follow-up of chronic hepatitis B patients treated with interferon alfa",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Lok",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "T"
                    ],
                    "last": "Chung",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "W"
                    ],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "C"
                    ],
                    "last": "Ma",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Gastroenterology",
            "volume": "105",
            "issn": "",
            "pages": "1833--1838",
            "other_ids": {}
        },
        "BIBREF121": {
            "ref_id": "b121",
            "title": "Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Madejon",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Cotonat",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bartolome",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Castillo",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Carreno",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Hepatology",
            "volume": "19",
            "issn": "",
            "pages": "1331--1336",
            "other_ids": {}
        },
        "BIBREF122": {
            "ref_id": "b122",
            "title": "Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "K"
                    ],
                    "last": "Manesis",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Hadziyannis",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Gastroenterology",
            "volume": "121",
            "issn": "",
            "pages": "101--109",
            "other_ids": {}
        },
        "BIBREF123": {
            "ref_id": "b123",
            "title": "Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Manns",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "K"
                    ],
                    "last": "Rustgi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Shiffman",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Reindollar",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "D"
                    ],
                    "last": "Goodman",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Koury",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ling",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Albrecht",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Lancet",
            "volume": "358",
            "issn": "",
            "pages": "958--965",
            "other_ids": {}
        },
        "BIBREF124": {
            "ref_id": "b124",
            "title": "Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "K"
                    ],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Bonino",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Farci",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hadziyannis",
                    "suffix": ""
                },
                {
                    "first": "Jin",
                    "middle": [
                        "R"
                    ],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "M"
                    ],
                    "last": "Piratvisuth",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Germanidis",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Yurdaydin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Diago",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gurel",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "Y"
                    ],
                    "last": "Button",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Pluck",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "N Engl J Med",
            "volume": "351",
            "issn": "",
            "pages": "1206--1217",
            "other_ids": {}
        },
        "BIBREF125": {
            "ref_id": "b125",
            "title": "Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Marcello",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Grakoui",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Barba-Spaeth",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "S"
                    ],
                    "last": "Machlin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "V"
                    ],
                    "last": "Kotenko",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Macdonald",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Rice",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Gastroenterology",
            "volume": "131",
            "issn": "",
            "pages": "1887--1898",
            "other_ids": {}
        },
        "BIBREF126": {
            "ref_id": "b126",
            "title": "IFN-tau: a novel subtype I IFN1. Structural characteristics, nonubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Martal",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "M"
                    ],
                    "last": "Chene",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "P"
                    ],
                    "last": "Huynh",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "&apos;haridon",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Reinaud",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "B"
                    ],
                    "last": "Guillomot",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Charlier",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Charpigny",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Biochimie",
            "volume": "80",
            "issn": "",
            "pages": "755--777",
            "other_ids": {}
        },
        "BIBREF127": {
            "ref_id": "b127",
            "title": "Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "R"
                    ],
                    "last": "Schiff",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Shiffman",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "M"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "K"
                    ],
                    "last": "Rustgi",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "D"
                    ],
                    "last": "Goodman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Ling",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Cort",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Albrecht",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "N Engl J Med",
            "volume": "339",
            "issn": "",
            "pages": "1485--1492",
            "other_ids": {}
        },
        "BIBREF128": {
            "ref_id": "b128",
            "title": "Sustained virologic response (SVR) to interferon-alpha-2b + /\u2212 ribavirin therapy at 6 months reliably predicts long-term clearance of HCV at 5-year follow-up",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Shiffman",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Lindsay",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Morgan",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Norkrans",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Esteban-Mur",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Poynard",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Pockros",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Albrecht",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Hepatol",
            "volume": "44",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF129": {
            "ref_id": "b129",
            "title": "Results of an interim analysis of a Phase II study of telaprevir (VX-950) with peginterferon alfa-2a and ribavirin in previously untreated subjects with hepatitis C",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "T"
                    ],
                    "last": "Everson",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Jacobson",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kauffman",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mcnair",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Muir",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Hepatol",
            "volume": "46",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF130": {
            "ref_id": "b130",
            "title": "Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Manns",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Brown",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Reddy",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Shiffman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Wong",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Am J Gastroenterol",
            "volume": "102",
            "issn": "",
            "pages": "880--889",
            "other_ids": {}
        },
        "BIBREF131": {
            "ref_id": "b131",
            "title": "Consensus interferon versus interferon-alpha 2b plus ribavirin in patients with relapsing HCV infection",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Miglioresi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bacosi",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Russo",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Patrizi",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Saccenti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ursitti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "D"
                    ],
                    "last": "Angelis",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "L"
                    ],
                    "last": "Ricci",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Hepatol Res",
            "volume": "27",
            "issn": "",
            "pages": "253--259",
            "other_ids": {}
        },
        "BIBREF132": {
            "ref_id": "b132",
            "title": "Intravenous natural beta-interferon in white patients with chronic hepatitis C who are nonresponders to alpha-interferon",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Montalto",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tripi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cartabellotta",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fulco",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Soresi",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Gaetano",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Carroccio",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Levrero",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Am J Gastroenterol",
            "volume": "93",
            "issn": "",
            "pages": "950--953",
            "other_ids": {}
        },
        "BIBREF133": {
            "ref_id": "b133",
            "title": "High dose consensus interferon in nonresponders to interferon alpha-2b and ribavirin with chronic hepatitis C",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "N"
                    ],
                    "last": "Moskovitz",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Manoharan",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "J"
                    ],
                    "last": "Heathcote",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Can J Gastroenterol",
            "volume": "17",
            "issn": "",
            "pages": "479--482",
            "other_ids": {}
        },
        "BIBREF134": {
            "ref_id": "b134",
            "title": "A pilot study of beta-interferon for treatment of patients with chronic hepatitis B who failed to respond to alpha-interferon",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Munoz",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Castellano",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Fernandez",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "V"
                    ],
                    "last": "Alvarez",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Manzano",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Marcos",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Cuenca",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Solis-Herruzo",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Hepatol",
            "volume": "37",
            "issn": "",
            "pages": "655--659",
            "other_ids": {}
        },
        "BIBREF135": {
            "ref_id": "b135",
            "title": "Synthesis in E. coli of a polypeptide with human leukocyte interferon activity",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nagata",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Taira",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hall",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Johnsrud",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Streuli",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ecsodi",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Boll",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Cantell",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Weissmann",
                    "suffix": ""
                }
            ],
            "year": 1980,
            "venue": "Nature",
            "volume": "284",
            "issn": "",
            "pages": "316--320",
            "other_ids": {}
        },
        "BIBREF136": {
            "ref_id": "b136",
            "title": "Anti-viral actions and viral dynamics in the early phase of three different regimens of interferon treatment for chronic hepatitis C: differences between the twice-daily administration of interferon-beta treatment and the combination therapy with interferon-alpha plus ribavirin",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Nakajima",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shimomura",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Iwasaki",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ikeda",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Umeoka",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Chengyu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Taniguchi",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ohnishi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Takagi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Fujioka",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Shiratori",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Acta Med Okayama",
            "volume": "57",
            "issn": "",
            "pages": "217--225",
            "other_ids": {}
        },
        "BIBREF137": {
            "ref_id": "b137",
            "title": "Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Neumann",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Polis",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Rozenberg",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Jackson",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Reitano",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mclaughlin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Koratich",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dewar",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Masur",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Haagmans",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kottilil",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "AIDS",
            "volume": "21",
            "issn": "",
            "pages": "1855--1865",
            "other_ids": {}
        },
        "BIBREF138": {
            "ref_id": "b138",
            "title": "Longterm follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Niederau",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Heintges",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lange",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Goldmann",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Niederau",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mohr",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Haussinger",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "N Engl J Med",
            "volume": "334",
            "issn": "",
            "pages": "1422--1427",
            "other_ids": {}
        },
        "BIBREF139": {
            "ref_id": "b139",
            "title": "Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Niro",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ciancio",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Tillman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lagget",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Olivero",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Perri",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Fontana",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Little",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Campbell",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Smedile",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Manns",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Andriulli",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rizzetto",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Aliment Pharmacol Ther",
            "volume": "22",
            "issn": "",
            "pages": "227--232",
            "other_ids": {}
        },
        "BIBREF140": {
            "ref_id": "b140",
            "title": "Treatment of hepatitis D",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Niro",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Rosina",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rizzetto",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Viral Hepat",
            "volume": "12",
            "issn": "",
            "pages": "2--9",
            "other_ids": {}
        },
        "BIBREF141": {
            "ref_id": "b141",
            "title": "Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Niro",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ciancio",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "B"
                    ],
                    "last": "Gaeta",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Smedile",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Marrone",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Olivero",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Stanzione",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "David",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Brancaccio",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Fontana",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Perri",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Andriulli",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rizzetto",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "44",
            "issn": "",
            "pages": "713--720",
            "other_ids": {}
        },
        "BIBREF142": {
            "ref_id": "b142",
            "title": "Phase 2 study of omega interferon alone or in combination with ribavirin in subjects with chronic hepatitis C genotype-1 infection",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Novozhenov",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Zakharova",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Vinogradova",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Nikitin",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "V"
                    ],
                    "last": "Gorbakov",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Yakovlev",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pak",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Rafalski",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bogomolov",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Alessi",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Blanchett",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Langecker",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mcnally",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Hepatol",
            "volume": "46",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF143": {
            "ref_id": "b143",
            "title": "Viral infections activate types I and III interferon genes through a common mechanism",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Onoguchi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yoneyama",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Takemura",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Akira",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Taniguchi",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Namiki",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Fujita",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Biol Chem",
            "volume": "282",
            "issn": "",
            "pages": "7576--7581",
            "other_ids": {}
        },
        "BIBREF144": {
            "ref_id": "b144",
            "title": "Pharmacokinetic and pharmacodynamic studies of a human serum albumininterferon-alpha fusion protein in cynomolgus monkeys",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Osborn",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "S"
                    ],
                    "last": "Olsen",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Nardelli",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Murray",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "X"
                    ],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Garcia",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Moody",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "S"
                    ],
                    "last": "Zaritskaya",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Sung",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Pharmacol Exp Ther",
            "volume": "303",
            "issn": "",
            "pages": "540--548",
            "other_ids": {}
        },
        "BIBREF145": {
            "ref_id": "b145",
            "title": "A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities",
            "authors": [
                {
                    "first": "O",
                    "middle": [
                        "N"
                    ],
                    "last": "Ozes",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Reiter",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Klein",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Blatt",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Taylor",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Interferon Res",
            "volume": "12",
            "issn": "",
            "pages": "55--59",
            "other_ids": {}
        },
        "BIBREF146": {
            "ref_id": "b146",
            "title": "The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "V"
                    ],
                    "last": "Papatheodoridis",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Manesis",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Hadziyannis",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Hepatol",
            "volume": "34",
            "issn": "",
            "pages": "306--313",
            "other_ids": {}
        },
        "BIBREF147": {
            "ref_id": "b147",
            "title": "Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "K"
                    ],
                    "last": "Parvez",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sehgal",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Sarin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "F"
                    ],
                    "last": "Basir",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jameel",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "World J Gastroenterol",
            "volume": "12",
            "issn": "",
            "pages": "3006--3014",
            "other_ids": {}
        },
        "BIBREF148": {
            "ref_id": "b148",
            "title": "Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Pastore",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Santantonio",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Milella",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Monno",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Mariano",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Moschetta",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Pollice",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Hepatol",
            "volume": "14",
            "issn": "",
            "pages": "221--225",
            "other_ids": {}
        },
        "BIBREF149": {
            "ref_id": "b149",
            "title": "Therapy of hepatitis C: from empiricism to eradication",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Pawlotsky",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "43",
            "issn": "",
            "pages": "207--220",
            "other_ids": {}
        },
        "BIBREF150": {
            "ref_id": "b150",
            "title": "The hepatitis C virus life cycle as a target for new antiviral therapies",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Pawlotsky",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chevaliez",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Gastroenterology",
            "volume": "132",
            "issn": "",
            "pages": "1979--1998",
            "other_ids": {}
        },
        "BIBREF151": {
            "ref_id": "b151",
            "title": "Antiviral action of ribavirin in chronic hepatitis C",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Pawlotsky",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Dahari",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "U"
                    ],
                    "last": "Neumann",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hezode",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Germanidis",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Lonjon",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Castera",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Dhumeaux",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Gastroenterology",
            "volume": "126",
            "issn": "",
            "pages": "703--714",
            "other_ids": {}
        },
        "BIBREF152": {
            "ref_id": "b152",
            "title": "Interferon modulation of cellular microRNAs as an antiviral mechanism",
            "authors": [
                {
                    "first": "I",
                    "middle": [
                        "M"
                    ],
                    "last": "Pedersen",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Wieland",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Volinia",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Croce",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "V"
                    ],
                    "last": "Chisari",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "David",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Nature",
            "volume": "449",
            "issn": "",
            "pages": "919--922",
            "other_ids": {}
        },
        "BIBREF153": {
            "ref_id": "b153",
            "title": "Interferons and their actions",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pestka",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Langer",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "C"
                    ],
                    "last": "Zoon",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "E"
                    ],
                    "last": "Samuel",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "Annu Rev Biochem",
            "volume": "56",
            "issn": "",
            "pages": "727--777",
            "other_ids": {}
        },
        "BIBREF154": {
            "ref_id": "b154",
            "title": "Interferons, interferon-like cytokines, and their receptors",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pestka",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "D"
                    ],
                    "last": "Krause",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Walter",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Immunol Rev",
            "volume": "202",
            "issn": "",
            "pages": "8--32",
            "other_ids": {}
        },
        "BIBREF155": {
            "ref_id": "b155",
            "title": "Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Peters",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Walling",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kelly",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "L"
                    ],
                    "last": "Davis",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Waggoner",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Hoofnagle",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "J Immunol",
            "volume": "137",
            "issn": "",
            "pages": "3147--3152",
            "other_ids": {}
        },
        "BIBREF156": {
            "ref_id": "b156",
            "title": "Wellferon\") prophylaxis against rhinovirus and influenza virus in volunteers",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Phillpotts",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "G"
                    ],
                    "last": "Higgins",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Willman",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Tyrrell",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "S"
                    ],
                    "last": "Freestone",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "M"
                    ],
                    "last": "Shepherd",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "J Interferon Res",
            "volume": "4",
            "issn": "",
            "pages": "535--541",
            "other_ids": {}
        },
        "BIBREF157": {
            "ref_id": "b157",
            "title": "Open-labeled study of omega interferon in previously untreated HCVinfected patients",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Plauth",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Meisel",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Langecker",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Moran",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Blanchett",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "U"
                    ],
                    "last": "Jetschmann",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Brack",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Von Wussow",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Proceedings of the 37th annual meeting EASL",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF158": {
            "ref_id": "b158",
            "title": "Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Poli",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Orenstein",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kinter",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Folks",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Fauci",
                    "suffix": ""
                }
            ],
            "year": 1989,
            "venue": "Science",
            "volume": "244",
            "issn": "",
            "pages": "575--577",
            "other_ids": {}
        },
        "BIBREF159": {
            "ref_id": "b159",
            "title": "Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Poynard",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Niederau",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "S"
                    ],
                    "last": "Minuk",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ideo",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Bain",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Heathcote",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zeuzem",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Trepo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Albrecht",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Lancet",
            "volume": "352",
            "issn": "",
            "pages": "1426--1432",
            "other_ids": {}
        },
        "BIBREF160": {
            "ref_id": "b160",
            "title": "Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Rahal",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Anderson",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rosenberg",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Reagan",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "L"
                    ],
                    "last": "Thompson",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Infect Dis",
            "volume": "190",
            "issn": "",
            "pages": "1084--1087",
            "other_ids": {}
        },
        "BIBREF161": {
            "ref_id": "b161",
            "title": "Current status of subjects receiving peginterferon alfa-2a (PEG-IFN) and ribavirin (RBV) follow-on therapy after 28-day treatment with the hepatitis C protease inhibitor telaprevir (VX-950), PEG-IFN and RBV",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rodriguez-Torres",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lawitz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Muir",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Keane",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "L"
                    ],
                    "last": "Kieffer",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mcnair",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "44",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF162": {
            "ref_id": "b162",
            "title": "A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Rosina",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Pintus",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Meschievitz",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rizzetto",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "Hepatology",
            "volume": "13",
            "issn": "",
            "pages": "1052--1056",
            "other_ids": {}
        },
        "BIBREF163": {
            "ref_id": "b163",
            "title": "Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Sainz",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "C"
                    ],
                    "last": "Mossel",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Peters",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "F"
                    ],
                    "last": "Garry",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Virology",
            "volume": "329",
            "issn": "",
            "pages": "11--17",
            "other_ids": {}
        },
        "BIBREF164": {
            "ref_id": "b164",
            "title": "Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Santantonio",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Niro",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Sinisi",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Leandro",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Insalata",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Guastadisegni",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Facciorusso",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Gravinese",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Andriulli",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Pastore",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Hepatol",
            "volume": "36",
            "issn": "",
            "pages": "799--804",
            "other_ids": {}
        },
        "BIBREF165": {
            "ref_id": "b165",
            "title": "Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Santantonio",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fasano",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Sinisi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Guastadisegni",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Casalino",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mazzola",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Francavilla",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Pastore",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Hepatol",
            "volume": "42",
            "issn": "",
            "pages": "329--333",
            "other_ids": {}
        },
        "BIBREF166": {
            "ref_id": "b166",
            "title": "Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Saracco",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Rosina",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Brunetto",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Amoroso",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Caredda",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Farci",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Piantino",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Bonino",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rizzetto",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "J Hepatol",
            "volume": "5",
            "issn": "",
            "pages": "274--281",
            "other_ids": {}
        },
        "BIBREF167": {
            "ref_id": "b167",
            "title": "Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Sarin",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "N"
                    ],
                    "last": "Kazim",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Guptan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sakhuja",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "C"
                    ],
                    "last": "Sharma",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Am J Gastroenterol",
            "volume": "100",
            "issn": "",
            "pages": "2463--2471",
            "other_ids": {}
        },
        "BIBREF168": {
            "ref_id": "b168",
            "title": "Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Sarin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sood",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Arora",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Amrapurkar",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "C"
                    ],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Konar",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "K"
                    ],
                    "last": "Chawla",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "K"
                    ],
                    "last": "Jain",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Nanda",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hissar",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Lavate",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lahoti",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Am J Gastroenterol",
            "volume": "102",
            "issn": "",
            "pages": "96--104",
            "other_ids": {}
        },
        "BIBREF169": {
            "ref_id": "b169",
            "title": "Dynamic HCV genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir (VX-950)",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Sarrazin",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "L"
                    ],
                    "last": "Kieffer",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Bartels",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hanzelka",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Muh",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Welker",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wincheringer",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Weegink",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "W"
                    ],
                    "last": "Reesink",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zeuzem",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "D"
                    ],
                    "last": "Kwong",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Gastroenterology",
            "volume": "132",
            "issn": "",
            "pages": "1767--1777",
            "other_ids": {}
        },
        "BIBREF170": {
            "ref_id": "b170",
            "title": "Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Scagnolari",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Vicenzi",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Bellomi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Stillitano",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Pinna",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Poli",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Clementi",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Dianzani",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Antonelli",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Antivir Ther",
            "volume": "9",
            "issn": "",
            "pages": "1003--1011",
            "other_ids": {}
        },
        "BIBREF171": {
            "ref_id": "b171",
            "title": "Antiviral innate immunity pathways",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "B"
                    ],
                    "last": "Seth",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "J"
                    ],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Cell Res",
            "volume": "16",
            "issn": "",
            "pages": "141--147",
            "other_ids": {}
        },
        "BIBREF172": {
            "ref_id": "b172",
            "title": "IL-28, IL-29 and their class II cytokine receptor IL-28R",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sheppard",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Kindsvogel",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Henderson",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Schlutsmeyer",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "E"
                    ],
                    "last": "Whitmore",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kuestner",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Garrigues",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Birks",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Roraback",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ostrander",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Shin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Presnell",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Fox",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Haldeman",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Cooper",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Taft",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Gilbert",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "J"
                    ],
                    "last": "Grant",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tackett",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Krivan",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Mcknight",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Clegg",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Foster",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Klucher",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Nat Immunol",
            "volume": "4",
            "issn": "",
            "pages": "63--68",
            "other_ids": {}
        },
        "BIBREF173": {
            "ref_id": "b173",
            "title": "Sequential treatment with lamivudine and interferon-alpha monotherapies in hepatitis B e antigennegative Chinese patients and its suppression of lamivudine-resistant mutations",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "F"
                    ],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Han",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "J"
                    ],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "J"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "P"
                    ],
                    "last": "Xu",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Antimicrob Chemother",
            "volume": "58",
            "issn": "",
            "pages": "1031--1035",
            "other_ids": {}
        },
        "BIBREF174": {
            "ref_id": "b174",
            "title": "High viral eradication with a daily 12-week natural interferon-beta treatment regimen in chronic hepatitis C patients with low viral load",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Shiratori",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Nakata",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Shimizu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Katada",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hisamitsu",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Yasuda",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Matsumura",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Narita",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kawada",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Omata",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Dig Dis Sci",
            "volume": "45",
            "issn": "",
            "pages": "2414--2421",
            "other_ids": {}
        },
        "BIBREF175": {
            "ref_id": "b175",
            "title": "Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "W"
                    ],
                    "last": "Sidwell",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Huffman",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "P"
                    ],
                    "last": "Khare",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "B"
                    ],
                    "last": "Allen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Witkowski",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "K"
                    ],
                    "last": "Robins",
                    "suffix": ""
                }
            ],
            "year": 1972,
            "venue": "Science",
            "volume": "177",
            "issn": "",
            "pages": "705--706",
            "other_ids": {}
        },
        "BIBREF176": {
            "ref_id": "b176",
            "title": "Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Sjogren",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sjogren",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Lyons",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ryan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Santoro",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Reddy",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Bonkovsky",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Huntley",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Faris-Young",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Dig Dis Sci",
            "volume": "52",
            "issn": "",
            "pages": "1540--1547",
            "other_ids": {}
        },
        "BIBREF177": {
            "ref_id": "b177",
            "title": "Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Snoeck",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Wade",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Duff",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lamb",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Jorga",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Br J Clin Pharmacol",
            "volume": "62",
            "issn": "",
            "pages": "699--709",
            "other_ids": {}
        },
        "BIBREF178": {
            "ref_id": "b178",
            "title": "Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Solis",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Goubau",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Romieu-Mourez",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Genin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Civas",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hiscott",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Biochem Pharmacol",
            "volume": "72",
            "issn": "",
            "pages": "1469--1476",
            "other_ids": {}
        },
        "BIBREF179": {
            "ref_id": "b179",
            "title": "Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Solomon",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "M"
                    ],
                    "last": "Dung",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Wills",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kneen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gainsborough",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "V"
                    ],
                    "last": "Diet",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "T"
                    ],
                    "last": "Thuy",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "T"
                    ],
                    "last": "Loan",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "C"
                    ],
                    "last": "Khanh",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Vaughn",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "J"
                    ],
                    "last": "White",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Farrar",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "361",
            "issn": "",
            "pages": "821--826",
            "other_ids": {}
        },
        "BIBREF180": {
            "ref_id": "b180",
            "title": "Pilot study of interferon gamma for chronic hepatitis C",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Soza",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Heller",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ghany",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lutchman",
                    "suffix": ""
                },
                {
                    "first": "Jake",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Germain",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hsu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "H"
                    ],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hoofnagle",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Hepatol",
            "volume": "43",
            "issn": "",
            "pages": "67--71",
            "other_ids": {}
        },
        "BIBREF181": {
            "ref_id": "b181",
            "title": "Durable sustained virological response after treatment with peginterferon alfa-2a (Pegasys) alone or in combination with ribavirin (Copegus): 5-year follow-up and the criteria for a cure",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Swain",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "Y"
                    ],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Shiffman",
                    "suffix": ""
                },
                {
                    "first": "Wge",
                    "middle": [],
                    "last": "Cooksley",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Abergel",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Connell",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Diago",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Hepatol",
            "volume": "46",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF182": {
            "ref_id": "b182",
            "title": "Interferon signalling network in innate defence",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Takaoka",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yanai",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Cell Microbiol",
            "volume": "8",
            "issn": "",
            "pages": "907--922",
            "other_ids": {}
        },
        "BIBREF183": {
            "ref_id": "b183",
            "title": "Toll-like receptors and type I interferons",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Uematsu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Akria",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Biol Chem",
            "volume": "282",
            "issn": "",
            "pages": "15319--15323",
            "other_ids": {}
        },
        "BIBREF184": {
            "ref_id": "b184",
            "title": "IL-28 and IL-29: newcomers to the interferon family",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Uze",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Monneron",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Biochimie",
            "volume": "89",
            "issn": "",
            "pages": "729--734",
            "other_ids": {}
        },
        "BIBREF185": {
            "ref_id": "b185",
            "title": "Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alpha",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Van Der Ende",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Mulder",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Van Den Berge",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Blok",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Schutten",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "AIDS",
            "volume": "21",
            "issn": "",
            "pages": "1661--1662",
            "other_ids": {}
        },
        "BIBREF186": {
            "ref_id": "b186",
            "title": "Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Van Zonneveld",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Honkoop",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "E"
                    ],
                    "last": "Hansen",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "G"
                    ],
                    "last": "Niesters",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "D"
                    ],
                    "last": "Murad",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "De Man",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Schalm",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Janssen",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Hepatology",
            "volume": "39",
            "issn": "",
            "pages": "804--810",
            "other_ids": {}
        },
        "BIBREF187": {
            "ref_id": "b187",
            "title": "Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Van Zonneveld",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Zondervan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cakaloglu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Simon",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [
                        "S"
                    ],
                    "last": "Akarca",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "So",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Flink",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "De Man",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Schalm",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Janssen",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Liver Int",
            "volume": "26",
            "issn": "",
            "pages": "399--405",
            "other_ids": {}
        },
        "BIBREF188": {
            "ref_id": "b188",
            "title": "Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Vassiliadis",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Tziomalos",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Patsiaoura",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Zagris",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Giouleme",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Soufleris",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Grammatikos",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Theodoropoulos",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mpoumponaris",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Dona",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zezos",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Nikolaidis",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Orfanou-Koumerkeridou",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Balaska",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Eugenidis",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Gastroenterol Hepatol",
            "volume": "22",
            "issn": "",
            "pages": "1582--1588",
            "other_ids": {}
        },
        "BIBREF189": {
            "ref_id": "b189",
            "title": "Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Villa",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Trande",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Grottola",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Buttafoco",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Rebecchi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Stroffolini",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Callea",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Merighi",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Camellini",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zoboli",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Cosenza",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Miglioli",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Loria",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Iori",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Carulli",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Manenti",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Dig Dis Sci",
            "volume": "41",
            "issn": "",
            "pages": "1241--1247",
            "other_ids": {}
        },
        "BIBREF190": {
            "ref_id": "b190",
            "title": "Antiviral activity of the non-nucleoside polymerase inhibitor, HCV-796, in combination with pagylated interferon alfa-2b in treatment-naive patients with chronic HCV",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Villano",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Raible",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Harper",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Speth",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Chandra",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Shaw",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Bichier",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Hepatol",
            "volume": "46",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF191": {
            "ref_id": "b191",
            "title": "Immunomodulatory activities of IFN-gamma1b in combination with type I IFN: implications for the use of IFN-gamma1b in the treatment of chronic HCV infections",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Blatt",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "D"
                    ],
                    "last": "Seiwert",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Interferon Cytokine Res",
            "volume": "26",
            "issn": "",
            "pages": "473--483",
            "other_ids": {}
        },
        "BIBREF192": {
            "ref_id": "b192",
            "title": "Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "L"
                    ],
                    "last": "Weng",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "E"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Jia",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "F"
                    ],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Z"
                    ],
                    "last": "Xian",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "R"
                    ],
                    "last": "Mertens",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "M"
                    ],
                    "last": "Cai",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Dooley",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Clin Gastroenterol Hepatol",
            "volume": "3",
            "issn": "",
            "pages": "819--828",
            "other_ids": {}
        },
        "BIBREF193": {
            "ref_id": "b193",
            "title": "Circulating virus, interferon and antibody after vaccination with the 17-D strain of yellow-fever virus",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "F"
                    ],
                    "last": "Wheelock",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "A"
                    ],
                    "last": "Sibley",
                    "suffix": ""
                }
            ],
            "year": 1965,
            "venue": "N Engl J Med",
            "volume": "273",
            "issn": "",
            "pages": "194--198",
            "other_ids": {}
        },
        "BIBREF194": {
            "ref_id": "b194",
            "title": "Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wiegand",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Buggisch",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Boecher",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zeuzem",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Gelbmann",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Berg",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Kauffmann",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Kallinowski",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cornberg",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Jaeckel",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wedemeyer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Manns",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "43",
            "issn": "",
            "pages": "250--256",
            "other_ids": {}
        },
        "BIBREF195": {
            "ref_id": "b195",
            "title": "Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Wolters",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "Van Nunen",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Honkoop",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Vossen",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "G"
                    ],
                    "last": "Niesters",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Zondervan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "De Man",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Viral Hepat",
            "volume": "7",
            "issn": "",
            "pages": "428--434",
            "other_ids": {}
        },
        "BIBREF196": {
            "ref_id": "b196",
            "title": "Effect of alphainterferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A metaanalysis",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "K"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Cheung",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "O&apos;rourke",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "D"
                    ],
                    "last": "Naylor",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Detsky",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Heathcote",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Ann Intern Med",
            "volume": "119",
            "issn": "",
            "pages": "312--323",
            "other_ids": {}
        },
        "BIBREF197": {
            "ref_id": "b197",
            "title": "Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Wursthorn",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lutgehetmann",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dandri",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Volz",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Buggisch",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zollner",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Longerich",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Schirmacher",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Metzler",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zankel",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Fischer",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Currie",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Brosgart",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Petersen",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "44",
            "issn": "",
            "pages": "675--684",
            "other_ids": {}
        },
        "BIBREF198": {
            "ref_id": "b198",
            "title": "The RNA helicase RIG-I has an essential function in double-stranded RNAinduced innate antiviral responses",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yoneyama",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kikuchi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Natsukawa",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Shinobu",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Imaizumi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Miyagishi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Taira",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Akira",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Fujita",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Nat Immunol",
            "volume": "5",
            "issn": "",
            "pages": "730--737",
            "other_ids": {}
        },
        "BIBREF199": {
            "ref_id": "b199",
            "title": "Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Yurdaydin",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Bozkaya",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Cetinkaya",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Sahin",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Karaoguz",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Toruner",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Erkan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "O"
                    ],
                    "last": "Heper",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Erden",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Bozdayi",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Uzunalimoglu",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Viral Hepat",
            "volume": "12",
            "issn": "",
            "pages": "262--268",
            "other_ids": {}
        },
        "BIBREF200": {
            "ref_id": "b200",
            "title": "A multicenter randomized study comparing the efficacy of pegylated interferon-alpha-2a plus adefovir dipivoxil versus pegyated interferon-alpha-2a plus placebo versus adefovir dipivoxil for the treatment of chronic hepatitis delta hepatitis: the HEP-NET/International Delta Hepatitis Intervention Trial (HID-IT)",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Yurdaydin",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wedemeyer",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Dalekos",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Erhardt",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cakaloglu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Degertekin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gurel",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zeuzem",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Zachou",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Bozkaya",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "P"
                    ],
                    "last": "Dienes",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Bock",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Manns",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "44",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF201": {
            "ref_id": "b201",
            "title": "Antiviral response at week 12 following completion of treatment with Albinterferon alpha-2b plus ribavirin in genotype 1, IFN-naive, chronic hepatitis patients",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zeuzem",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Benhamou",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Bain",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Shouval",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pianko",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Flisiak",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Grigorescu",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Rehak",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Yoshida",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kaita",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "W"
                    ],
                    "last": "Cronin",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Pulkstenis",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Subramanian",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Mchutchison",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Hepatol",
            "volume": "46",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF202": {
            "ref_id": "b202",
            "title": "Genotype B and younger patient age associated with better response to lowdose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigenpositive patients with chronic hepatitis B in China",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Kurbanov",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B"
                    ],
                    "last": "Wan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "K"
                    ],
                    "last": "Yin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Q"
                    ],
                    "last": "Niu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Hou",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "Q"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tanaka",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mizokami",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "W"
                    ],
                    "last": "Si",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Clin Infect Dis",
            "volume": "44",
            "issn": "",
            "pages": "541--548",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Type I IFN production and signaling pathways. (a) Interferon regulatory factor 3 (IRF-3) activation.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Treatment of Other Viral Infections with Type I IFN in Humans. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 229 10 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "Characteristics of the principal human IFN genes",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "and Stephen J. Polyak, presentation at the Post-Graduate Course of the 41st Annual Meeting of the European Association for the Study of the Liver, Vienna",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "Interferon-induced antiviral effectors",
            "latex": null,
            "type": "table"
        },
        "TABREF5": {
            "text": "Pharmacological parameters of pegylated IFN-\u03b1 molecules approved for the treatment of chronic hepatitis C treatment of chronic hepatitis C in adults, namely pegylated IFN-\u03b12a and pegylated IFN-\u03b12b, in which the IFN-\u03b1 molecules are linked to PEG molecules of different sizes(Table 3).",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "Treatment of viral infections other than chronic viral hepatitis and HIV with type I IFNs No significant protection Isomura et al. 1982; Phillpotts et al. 1984 Coronavirus IFN-\u03b2 more protective than IFN-\u03b1 Sainz et al. 2004; Scagnolari et al. 2004 Synergistic effect of IFN-\u03b1 and IFN-\u03b2 Cytomegalovirus (CMV) No significant reduction of the risk of CMV disease Hodson et al. 2007 Reduced CMV viremia on IFN-\u03b1 treatment Arthropod-borne virus infections Under investigation Kalil et al. 2005; Lewis and Amsden 2007;",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}